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1 
Introduction 
This thesis describes studies on utilisation of spirometry and interpretation of 
spirometry test results in general practice Spirometry is an essential pulmonary 
function test in confirming chronic obstructive pulmonary disease (COPD), instable 
asthma or (more often) excluding airway obstruction in a diagnostic procedure of 
patients with symptoms such as dyspnoea, chronic cough, and chronic sputum 
production The aim of this thesis is to assess the impact of expert support for the 
interpretation of spirometry test results on the diagnostic achievements of general 
practitioners (GPs) 
Background 
Chronic obstructive pulmonary disease (COPD, referring to chronic bronchitis and 
emphysema) and asthma are prevalent chronic respiratory conditions that will 
continue to cause increased disability in the world's population in future years 1 
COPD and asthma are mainly diagnosed and treated in general practice in the 
Netherlands 
COPD is an airway disease usually characterised by progressive airflow limitation, 
that is not fully reversible 2 Smoking is considered to be the major cause of COPD 3 
Symptoms of COPD are dyspnoea, cough and sputum production Intermittent acute 
exacerbations often occur m the winter months as a result of infections The 
prevalence of COPD in the general population in the Netherlands is estimated at 
2,2% in men and 1,7% in women the prevalence increases with age and COPD is 
predominantly diagnosed in patients after 40 years4 In a general practice with 2,500 
patients 55 patients will have a physician diagnosis of COPD, generally 80% of these 
patients have mild or moderate COPD 4 Smoking cessation is the only successful 
intervention that can stop further decline of lung function 3 Medication treatment 
consists of bronchodilators and inhaled steroids 5 
Asthma can develop at any age, but is predominantly a childhood disease Asthma is 
characterised by increased bronchial hyperresponsiveness, intermittent and non-
productive cough, intermittent and variable breathlessness and/or nocturnal 
symptoms Contrary to COPD, the airflow obstruction is intermittent and usually fully 
reversible Airflow obstruction can occur in reaction to contact with allergenic and 
non-specific stimuli Concomitant eczema, allergic rhinitis and a positive family 
history for these signs and symptoms are common Spirometry, reversibility testing, 
and peak flow monitoring are diagnostic tools to assess a diagnosis of asthma 
Asthma is characterised by a normal or slightly obstructive lung function as measured 
with spirometry together with mostly full reversibility after inhaling bronchodilators 6 
Severity classification of asthma is staged on the presence of clinical symptoms and 
medication use intermittent, mild persistent, moderate and severe persistent57 In an 
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average general practice with 2,500 patients about 75 patients will have a physician 
diagnosis of asthma.8 Medication treatment consists of inhaled steroids and 
bronchodilators.5 
Spirometry tests 
In a diagnostic procedure of patients in general practice with symptoms such as 
dyspnoea, chronic cough, chronic sputum production, spirometry is essential in 
confirming (COPD or instable asthma) or (more often) excluding airway obstruction. 
Spirometry measures the forced vital capacity (FVC) - the maximum volume of air 
forcibly exhaled after full inspiration, the forced expiratory volume in one second 
(FEVi) - the volume of air exhaled during the first second of the FVC manoeuvre, 
and the FEVi /FVC ratio. In general practice, most spirometers produce the graphic 
results of a spirometry test; the flow volume curve (figure 1). The FEVi and FVC 
values are compared with predicted normal values for age, height, and sex and often 
expressed as the percentage predicted. Airflow obstruction is present if the FEVi 
/FVC ratio is <0.7 and the FEVi is <80% of the predicted value.6 Spirometry 
contributes to distinguish patients with COPD from patients with asthma as patients 
with CORD will always show irreversible airflow obstruction whereas patients with 
asthma may or may not show airflow obstruction. Spirometry allows patients with 
COPD to be staged according to severity of obstruction (mild, moderate, severe or 
very severe).2 
Figure 1 Example of a flow-volume curve 
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Spirometry is an important tool within the broad concept of management in chronic 
respiratory diseases (COPD and asthma) and is essential for diagnosing these 
conditions 6 The central role that has been assigned to spirometry in general practice 
guidelines calls for its widespread implementation in the general practice setting 
However, the mere existence of the guidelines alone by no means guarantees that 
GPs actually embrace spirometry and apply it consistently in diagnosing and 
managing patients who consult with respiratory symptoms 9 It seems that, despite the 
availability of the guidelines, there still are a number of practical barriers that impede 
wide implementation of quality spirometry facilities in general practice 
Availability of spirometers in general practice 
In 1998, at least a third of all general practices either owned a spirometer or had easy 
access to external spirometry services 10 Although there are no recent official 
estimates for the Netherlands, it's quite likely that the dissemination of electronic 
spirometers among GPs has further progressed during the past few years Several 
general practice studies indicate that introducing spirometry leads to considerable 
improvement m distinguishing COPD from asthma in subjects known to their GP as 
suffering from 'chronic respiratory disease'1114 The use of spirometry also 
contributes to the early detection of subjects with COPD or asthma in general 
practice 15 However, GPs interpret less than one spirometry test per week in daily 
practice 
Interpretation of spirometry tests 
The current thesis logically flows from a broad spirometry study on the validity of 
spirometry in general practice16 and on the diagnostic value of spirometry17 (HASPIR 
study huisarts en spirometrie) The results from the HASPIR study confirmed that the 
spirometrie parameters relevant for general practice (FEVi, FVC, and their ratio) are 
valid when measurements are performed in the general practice setting16 
Apparently, this crucial prerequisite for broad implementation of spirometry in general 
practice is met Taking this finding into consideration, the next question emerging is if 
GPs are able to draw the right conclusions from their spirometry tests Apart from 
these published HASPIR studies data was collected with questionnaires among 
participants of the HASPIR study to describe the utilisation and barriers to 
implementation of spirometry in primary care However, these data were not yet 
analysed 
Single training session 
In general practice postgraduate workshops of spirometry performance are often 
organised as part of continuous medical education However, the precise effect of a 
single training workshop on the interpretative capacity of GPs is at least doubtful A 
randomised study performed in New Zealand investigated the ability of GPs towards 
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interpretation of spirometry The investigators took random samples from the 
spirometry records of 15 GPs who had participated m a basic spirometry training 18 
Subsequently, the GPs had to label the spirometrie tests of their own subjects using 
seven pre-defined diagnoses (e g 'normal', 'obstructive disorder', 'inadequate test 
performance') Two chest physicians judged the interpretations of the GPs as correct 
in 53% of the cases, an almost similar percentage as in a reference group consisting 
of GPs who had not received spirometry training Results from a Dutch study show 
that GPs who have a special interest in respiratory disease are capable of 
differentiating between normal and obstructive disease patterns, whereas rare 
pathology (small airways disease, restrictive patterns and upper airway limitations) 
and mixed pathology patterns are likely to be missed 17 It is important to realise that -
like electrocardiography (EGG) - spirometry is a highly complex diagnostic tool in the 
perception of many GPs A systematic approach for judging the quality of tests and 
the subsequent assessment of the relevant lung function indices (FEVL FEVI/FVC), 
the accompanying predicted values, and the graphical output that most electronic 
spirometers provide (flow-volume and time-volume curves) seems difficult 
Apparently, a basic training program alone is not sufficient to acquire the specific 
knowledge, skills and expertise necessary to interpret spirometry tests adequately 
Spirometry expert support 
Ideally, the interpretative skills and confidence levels of GPs are supported after 
appropriate initial spirometry training Understanding of the process of spirometry 
interpretation could be enhanced by organising ongoing expert support One can 
think of three realistic modes to organise this 'expert support' m Dutch primary health 
care (1) periodic repetition of postgraduate spirometry training for GPs, (2) 'case-
specific' expert consultation or feedback from a secondary care respiratory consultant 
or (3) 'real-time' support by a computerised spirometry expert system 
The first option is rather time-consuming and non-specific the information offered 
during training sessions does not pertain to a particular subject a GP would like to 
have an expert opinion on in the daily practice setting 
The second option is supported by the published 'national primary-secondary care 
working agreements' ('Landelijke Transmurale Afspraken') between GPs and chest 
physicians with regard to the diagnosing and management of COPD and asthma 1920 
These working agreements - or parts of them - have already been implemented in 
some regions in the Netherlands (e g , Nijmegen, Eindhoven), without any prior 
evaluation of the consequences A disadvantage of implementing the working 
agreements is the amount of time demanded from respiratory consultants, a clear 
advantage is that the consultant may include additional (non-spirometnc) diagnostic 
information in his/her judgement 
The third option, a computerised spirometry expert system, may be an efficient 
alternative option no time investment of respiratory consultants is required, 
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interpretation of spirometry tests can be requested by the GP at any time, and 
archiving of the expert information occurs automatically. 
In 2000, a consensus group of experts (wvvw.spirxpert.com/spirxpertqroup.htm) 
developed a computerised expert system to support GPs in their interpretation of 
spirometry test results with funding of the Dutch Asthma Foundation. The expert 
system interprets pre-and post-bronchodilator FEV^ FVC and FEV-i/FVC values 
(graphical interpretation in Figure 2) and provides the GP with suggestions for further 
diagnostic testing when applicable (textual interpretation in Figure 2). The spirometry 
software expert system (SpirXP®, currently marketed as SpidaXpert® by Micro 
Medical Ltd, Kent, UK)21 is now commercially available. Empirical studies on the 
effect of this kind of ongoing expert support on the interpretative capacity of GPs are 
not available at this time. 
Figure 2 Example of a computerised spirometry expert system 
This thesis: objective and research questions 
The main objective of this thesis is to assess the impact of expert support for the 
interpretation of spirometry test results on the diagnostic achievements of general 
practitioners. 
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Research questions: 
1 For which indications do GPs use spirometry, and which GP- and practice-
related factors are associated with its use? 
2 Is there a need for ongoing support for spirometry test results among GPs, 
and which characteristics of GPs and their practice settings are associated 
with GPs' need for ongoing support? 
3 What is the effect of spirometry software expert support on the diagnostic 
achievements of GPs, and on GPs' decision-making m diagnosing chronic 
respiratory disease? 
4 What is the effect of spirometry software expert support or chest physician 
support on GPs' diagnosis and subsequent management of chronic respiratory 
disease? 
Outline of the thesis 
Chapter 2 describes the results of a questionnaire survey of 61 GPs involved in a 
spirometry evaluation program We explored the extent of spirometry utilisation for 
five indications from national COPD & asthma guidelines and we identified GP- and 
practice-related factors associated with spirometry utilisation In chapter 3 we 
present the results of a questionnaire survey among 137 GPs who participated in the 
before mentioned spirometry evaluation program We identified characteristics of 
GPs and their practice settings associated with GP's need for ongoing support for 
spirometry interpretation In chapter 4 we summarise in an editorial the need for 
ongoing expert support for the interpretation of spirometry tests by GPs We highlight 
the importance of close collaboration between primary and secondary care with 
respect to spirometry test interpretation Chapter 5 describes the results of a cluster-
randomised controlled trial to assess m a simulated setting the impact of 
computerised spirometry interpretation expert support on the diagnostic 
achievements of GPs, and on GPs' decision-making in diagnosing chronic respiratory 
disease Chapter 6 describes the results of another cluster-randomised controlled 
trial to assess the impact of two modes of expert support (computerised expert 
support and consultation by a chest physician) for the interpretation of spirometry 
tests on GPs' diagnosis and subsequent management of chronic respiratory disease 
in real patients 
Finally, chapter 7 contains the general discussion of the mam results and 
conclusions of this thesis 
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ORIGINAL ARTICLE 
Variation in spirometry utilization between trained general 
practitioners in practices equipped with a spirometer 
PATRICK J. P. P O E L S 1 , TJARD R. J. S C H E R M E R 1 , A N N E L I E S JACOBS 2 , REINIER P. 
A K K E R M A N S 1 , J O L I E T H A R T M A N 2 , BEN A. M. B O T T E M A 1 ' 2 & CHRIS VAN WEEL 1 
1
 Department of General Prauice, Radboud University Nijmegen Medical Centre, and 'Centre for Quality of Care Research, 
Radboud University Nijmegen Medical Centre, The Netherlands 
Abstract 
Objective To explore spirometry utilization among general practitioners and identity· practitioner and practice-related 
factors associated with spirometry utilization Design. Multivariate multilevel cross-sectional analysis of a questionnaire 
survey. Setting Some 61 general practices involved in a spirometry evaluation programme in the Netherlands All practices 
owned a spirometer and were trained to perform spirometry. Subjects. A total of 144 general practitioners and 179 practice 
assistants. Mam outcome measures. Extent of spirometry utilization for five indications from national COPD/asthma 
guidelines, practitioner and practice-related factors associated with spirometry utilization. Results. The response rate was 
97%. General practitioners used spirometry mostly to evaluate treatment with inhaled steroids (58%) Significant 
practitioner-related factors associated with spirometry utilization were, general practitioners' job satisfaction, general 
practitioners' general interest in research, and prior participation in spirometry training Practice-related factors associated 
with spirometry utilization were presence of a practice nurse, delegation of medical tasks to practice assistants, use of 
spirometry in different rooms, and use of protocols in practice. Conclusion. Practitioner- as well as practice-related factors 
were associated with the extent of spirometry utilization. In particular, it is essential to improve practice-related factors (e g. 
presence of a practice nurse, more delegation of medical tasks to the practice assistant) 
Key Words: Asthma, COPD, family practice, primary care, spirometry 
In recent years the number of spirometers in primary 
care has increased. Currently general practitioners' 
(GPs) ownership of a spirometer varies between 
60% and 80% in the UK [1,2]. In general practice, 
equipment is no longer a limiting factor for spiro-
metry utilization as rather inexpensive and reliable 
electronic spirometers have become widely available. 
According to guidelines for general practice [3] and 
respiratory care [4], spirometry constitutes an essen-
tial tool to determine the presence and severity of 
airflow obstruction, and to distinguish between 
reversible and irreversible obstruction. The Dutch 
College of General Practitioners' guideline on 
COPD [5] states that availability of spirometry is 
an essential precondition for GPs to test and treat 
most patients with mild or moderately severe COPD. 
Correspondence Patrick J 1' Pools, Peparrment of General Practice, Radboud Lmscrsm \i)mi.gcn Medical Centre, PO Box 9101, NL-65ÜÜ HD Nijmegen, 
The Netherlands h-mail ρ ] ρ pods u hag umen nl 
Although spirometry is feasible in primary care, 
general practitioners (GPs) experience barriers 
that impede its utilization. 
• Dutch GPs used spirometry mostly to eval­
uate a recently initiated treatment with 
inhaled steroids. 
• Trained GPs with a special interest in 
research, with adequate resources and in a 
practice providing structured care, are more 
likely to use spirometry. 
• In particular, practice-related factors (e.g. 
presence of a practice nurse, delegation of 
medical tasks) are primordial to improve 
spirometry. 
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Carrying out spirometry in general practice 
seems justified in terms of test validity, provided 
that practice staff have been trained sufficiently 
[6]. This creates an essential precondition for 
implementation of spirometry in the general prac-
tice setting, but by no means guarantees actual 
integration of spirometry in the GP's management 
of respiratory diseases [7 9]. It seems that there 
are still barriers with regard to successful imple-
mentation of spirometry in primary care. Local 
factors like inadequate reimbursement of spirome-
try in own practice [10], and its general complexity 
to fit it into daily practice are well-documented 
common barriers that could explain a variation 
in spirometry utilization between GPs [1,11]. 
The variation in spirometry utilization seems also 
to be linked to practitioner-related factors 
(e.g. GPs' spirometry training level) and practice-
related factors (e.g. being in a group practice) 
[12]. Little is known about which of these factors 
are easily modifiable and essential to improve. The 
objective of the present study was to explore 
spirometry utilization among trained and well-
equipped GPs. In order to give concrete direction 
to future reseach on this topic, we also identified 
practitioner- and practice-related factors that were 
associated with the extent of spirometry utilization 
by GPs. 
Approval was provided by the medical ethics 
review board of Radboud University Ni)megen 
Medical Centre. 
Material and methods 
Design and data collection 
A questionnaire survey was mailed to 61 practices 
involved in a spirometry evaluation programme [6]. 
In that study a pair of spirometrie tests (laboratory 
and general practice) was performed twice in about 
seven study subjects per practice. The current 
questionnaire survey took place 14 months after 
GPs and practice assistants had been offered 
an initial spirometry training programme, to ensure 
that practices had enough time to implement spiro-
metry for all patients in daily practice (not only 
for study purposes). All of these practices owned 
a spirometer (MicroLoop*, Micro Medical Ltd, 
Rochester, Kent, UK), spirometry software 
(Spirare®, Diagnostica Ltd, Oslo, Norway) and 
had at least one practice assistant employed who 
was trained to perform spirometry. (In Dutch 
primary care, practice assistants are professionally 
trained for administrative and clinical patient-direc-
ted support tasks). 
Questionnaires 
Discussion groups and interviews with experts in 
the fields were used to develop questionnaires to 
measure potential practitioner- and practice-related 
factors that may explain the extent of spirometry 
utilization by GPs We developed separate ques-
tionnaires for GPs and practice assistants. First, we 
sent a questionnaire to a contact person (GP) in 
each practice to collect general information on the 
characteristics of the practice setting, practice 
organization and equipment, and information re-
garding the composition of the practice staff. 
Second, we sent to all GPs and practice assistants 
involved in these practices a questionnaire regard-
ing the professional experience, general training 
level and continuous medical education, spirometry 
quality assurance, value of spirometry, and utiliza-
tion of spirometry in daily practice (only for GPs). 
We used items in this questionnaire from a 
validated instrument [13]. Considerable effort was 
expended to achieve an optimal response. A €22 
incentive was offered to practice staff for returning 
the questionnaires. We sent reminders to non-
responders at approximately four-week intervals, 
for a total of two mailings. Practices that did not 
respond to the reminders were telephoned by the 
researchers. 
Outcomes and analyses 
Spirometry utilization was assessed on the basis of 
GPs' self-reported utilization of spirometry for five 
indications for spirometry that are included in 
national GP guidelines for diagnosing and managing 
COPD and asthma (see Figure 1) [3,5,14] For each 
indication GPs rated the extent to which they 
applied spirometry in their daily practice: 0 = seldom 
or never; 1 = sometimes; 2 = often or always use of 
spirometry. A total sum score (range 0-10) for these 
five indications was calculated. 
The sum score was considered to reflect "GPs' 
spirometry utilization" and was used as the depen-
dent variable in subsequent analyses. Because of the 
hierarchical structure of the study (GPs clustered 
within practices) we performed a multilevel analy-
sis. In this analysis we accounted for the variability 
associated with each level of clustering. Analyses 
were performed in SAS V8.2 for Windows (SAS 
institute Ine, Cary USA 1999-2001) and were 
based on a mixed-effects model (PROC MIXED). 
In this model both fixed and random effects can 
be analysed. We used a random intercept model 
with practice as random variable and all other 
variables fixed. This means that we expected that 
the intercept varied randomly between practices 
and the other regression parameters in the model 
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Measuring response on a diagnostic 
prednisolone course 
Screening of smokers on chrome 
respiratory disease 
— . = — ^ 
lalways/often Β sometimes D seldom / never | 'missing for 2 GPs 
Figure 1. GPs' spirometry utilization for five indications that are included in the Dutch G P guidelines (n - 144*). 
had the same (fixed) value for each practice. The 
interpretation of the intercept and regression para­
meters is the same as in ordinary regression 
analyses, i.e. the value of each regression parameter 
(Beta) is corrected for the other variables in the 
model. 
Univariate multilevel analyses were applied to 
assess the dependency of GPs ' spirometry utilization 
on the explanatory variables. Multivariate multilevel 
analyses were applied with 23 explanatory variables. 
A backward elimination procedure was performed. 
Variables with a p-value of <0.05 remained in the 
final model (see Table II). The interclass correlation 
coefficient (ICC) was assessed to give insight into 
the proportion of variance that was accounted for by 
practice level. Also, the fraction of explained var­
iance at practice level and practitioner level was 
calculated. 
and group practices overrepresented among the 
practices in our study. 
Spirometry utilization 
GPs' spirometry utilization was normally distributed: 
mean 5.65 points (SD 2.47). Clustering of GPs 
within practices accounted for 16.8% of the total 
variation in GPs' spirometry utilization (ICC = 
0.168). Figure 1 shows GPs' spirometry utilization 
for the five indications included in the Dutch 
national GP guidelines. 
The indication for which the GPs reported the 
highest rate of spirometry utilization was "Evalua­
tion of recently initiated treatment with inhaled 
steroids in COPD or asthma patients" (58%). The 
indication with the lowest spirometry utilization rate 
was "Screening of smokers on chronic respiratory 
disease" (22%). 
Results 
Characteristics of general practices 
The response rate was 97% (59/61). Reasons for 
non-response of the practices remained unknown 
in one practice and one practice had merged recent­
ly with another practice that was not involved 
in the spirometry evaluation programme. In Table I 
we compare some characteristics of the general 
practices, GPs, and practice assistants involved 
in our study with national data from the Nether­
lands. Compared with the national figures, single-
handed practices were relatively underrepresented 
Practitioner- and practice-related factors and their 
association with spirometry utilization 
Table II shows the results of the stepwise multi­
variate multilevel analyses. The practitioner-related 
factors that were associated with GPs' spirometry 
utilization were GPs' job satisfaction (p =0.003), 
GPs' general interest in research (p=0.01), and 
GPs' participation in the spirometry training during 
the study (p =0.02). 
Practice-related factors associated with GPs ' spiro­
metry utilization were the presence of practice nurse 
support (p<0.001), the extent of delegation of 
medical tasks to practice assistants (p =0.003), use 
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Table I Characteristics of the general practices, genera] practitioners, and practice assistants involved in the study (left) and from 
national data in the Netherlands (right) Values are means (SD) unless otherwise stated 
General practices 
Type of practice, % 
Single-handed 
Duo 
Group ( £ 3 GPs) 
Multidisciplinary healthcare centre 
GPs, number per practice 
Practice assistants, number per practice 
Time since introduction of spirometry, years 
33 9 
27 1 
30 5 
85 
2 5 (1 4) 
3 1 ( 1 4 ) 
4 3 (2 9) 
60 7 
26 4 
12 9 
NA 
NA 
NA 
General practitioners =8209' 
Age,% <40 years 
Professional expenence, years 
Gender,% female 
Patients per GP, number per practice 
25 7 
14 3 (8 2) 
30 6 
1862 (771) 
21 
NA 
31 4 
2392 
Practice assistants 
Age,% <40 years 
Professional experience, years 
Gender,% female 
61 5 
10.7 (7 4) 
99 4 
± 6 8 
NA 
99 
'Data ( 1 January 2004) from the Netherlands Institute for Health Service Research (http //www nivel nl) 2Data ( 1 January 2004) from 
the Dutch Association of Dokters Assistants (personal communication) NA =no t available 
of spirometry in different rooms (p =0.007) in the 
practice, task differentiation among GPs within the 
same practice (p =0.01), and the use of protocols in 
practice (p=0.01). The fraction of explained var-
iance with this model was 26.3%. Furthermore, 
82.9% of all vanance at practice level and 14.9% 
of all vanance at GP level was explained. 
Discussion 
The results of this study indicate that GPs utilized 
spirometry mostly for diagnostic and monitoring 
purposes and seldom for screening purposes. We 
identified three practitioner- and five practice-re-
lated factors that were associated with the extent of 
spirometry utilization by GPs 
Table II Results of stepwise multivariate multilevel analyses 
Explanatory variable Reference category 
Practitioner-related factors 
Job satisfaction (subjective) 
General interest in scientific research 
Spirometry training during the study [6) 
Practice-related factors 
Practice nurse support 
Delegation medical tasks - practice assistants 
Spirometry used m different rooms 
Task differentiation among GPs 
Use of protocols in practice 
Point on sum score1 
Non-participant 
Non-attender 
No 2 
% point delegated tasks 
No 
No 
Point on sum score3 
0 197 
0 997 
0 883 
2 203 
0.042 
1.116 
- 1 104 
0 5 1 5 
0 003 
0 0 1 
0 02 
< 0 001 
0 003 
0 007 
0 01 
0 0 1 
0 070 
0 238-
0 116-
0 929-
0 0 1 5 -
0 313 
- 1 956 
0 112 
0 323 
-1 759 
-1 651 
-3.477 
-0 069 
-1 918 
- 0 252 
0 9 1 8 
Explanatory variables are sorted by descending p-value Explained fraction of vanance; R2 = 2 6 3 % 'Sum score (range 0 10) of five 
questions (Likert scale) concerning GP's satisfaction with available time for patients, work, continuous medical education, family, and 
leisure urne 2In Dutch primary care, practice nurses are professionally trained for support tasks, predominandy in chronic diseases (COPD 
& asthma or diabetes). They work under the supervision of a GP. They follow strict protocols for medical care and give education to 
patients They do not order additional investigations They are not allowed to refer patients Nowadays, they are increasingly employed in 
multidisciplinary healthcare centres or group practices 3Sum score (range 0 - 4 ) of five questions (yes = l ) n o = 0 ) with regard to the 
presence of protocols for visiting patients admitted to hospital, separate office hours for diabetes care or cardiovascular disease, invitation 
system for cervical cancer screening; invitation system for annual influenza vaccination 
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Strengths and weaknesses of the study 
One of the strengths of our study was an excellent 
response rate of almost 100% Furthermore, in an 
opportunistic setting (participants in a study on 
spirometry) we analysed the effect of introduction 
of spirometry in daily practice on GPs' self-reported 
actual utilization Through correction in the analyses 
for the fact that GPs were clustered in the same 
practices and may share one or more practice 
assistants, we could assess separately practitioner-
and practice-related factors that were associated with 
spirometry utilization Practices were all equipped 
with a spirometer as an integral part of the evalua-
tion Consequently, the absence of a spirometer was 
not a limiting factor with regard to the implementa-
tion of spirometry Generally, most trained GPs 
seem to prefer to perform spirometry in their own 
practice [15] We took into consideration all these 
aspects in the setting of our study 
We could explain 26 3% of all variance in GPs' 
spirometry utilization, the dependent variable in our 
analysis However, this subjective measure of good-
ness-of-fit also indicates that 73 7% of the variation 
could not be predicted with the current data In 
particular the variance at GP level could not be 
explained by this model Apparently, there are other 
(psychological) factors that influence utilization that 
have not been asked about in the questionnaires 
A weakness of the study is the external validity We 
could only analyse GPs' perception of their actual 
use of spirometrv once equipment was available and 
staff had been trained in its use Due to selective 
participation of GPs with a general interest in 
research and the fact that - compared with national 
data we included a relatively small proportion of 
single-handed practices our findings may not fully 
reflect the situation in Dutch general practice as a 
whole Because no national data on spirometry 
ownership of general practices are available for the 
Netherlands, we do not know to what proportion of 
all practices our findings apply 
From a methodological point of view we accept 
that objective assessment of GPs' actual use of 
spirometry instead of the perception of use would 
have been more sophisticated As there was an 
almost complete lack of studies in this area, we 
chose to explore spirometry utilization by GPs first 
by questionnaire There have been contradictory 
reports as to the accuracy of physicians' self-reported 
adherence to guidelines in the literature On the one 
hand, questionnaires tend to have moderate to high 
concordance with other less subjective measures 
of adherence [16] On the other hand, clinicians' 
self-reported adherence rates may also exceed objec-
tive rates, which may result in an overcstimation 
of adherence of up to 25% [17] In our case, there is 
no reason to assume that the degree of overestima-
tion of spirometry utilization if indeed present -
would be different for the five separate indications 
for spirometry from the national guidelines for GPs 
that were studied One could also wonder whether a 
consistent overestimation would have given different 
results with regard to the observed associations 
between practitioner- and practice-related factors 
and spirometry utilization rates Although we used 
five indications for spirometry from guidelines to 
assess a total sum score, we do realize that the role of 
spirometry in diagnostics and monitoring of asthma 
is still controversial in daily practice with regard to 
best practice 
Comparison with previous studies 
Generally, from this study and other studies [1,18] 
spirometry seems to be underused for several 
indications in primary healthcare The results of 
the current study indicate that GPs utilized spiro-
metry in daily practice not only for diagnosis of 
respiratory diseases but also for management pur-
poses Specific utilization of spirometry for manage-
ment purposes in primary care has been reported 
previously [1,18] In line with these studies [1,18] 
GPs' utilization of spirometry for screening purposes 
in asymptomatic smokers was very low (22%), which 
seems legitimate considering the current view that 
widespread screening of smokers for the presence of 
airflow obstruction cannot be recommended at this 
time [19] 
To the best of our knowledge this is the first study 
that assessed by means of multivariate multilevel 
analyses practitioner- and practice-related factors 
that were associated with spirometry utilization 
Presently, only one study is available to mirror our 
results O'Dowd et al [12] determined physician-
related and practice-related factors that were 
associated with owning a spirometer and use of 
spirometry in the evaluation of new asthma patients 
Factors associated with frequent use of spirometry 
among GPs were ownership of a spirometer, GPs' 
belief that such testing provides data necessary for a 
diagnosis and, finally, a sufficient level of training to 
perform and interpret these tests In our study all 
practices owned a spirometer but we also found an 
association between adequate training level to inter-
pret tests (p =0 02) and actual utilization of spiro-
metry by GPs 
Possible implications for clinical practice 
The extent of spirometry utilization was associated 
with trained GPs with a special interest in research, 
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with adequate resources (e.g. support staff and room 
space) and practices providing structured care to 
patients (e.g. use of protocols). To attain such an 
optimal situation in one's own practice we suggest 
having a special practice nurse for respiratory 
diseases employed in a practice. Special office hours 
for respiratory diseases attended by this practice 
nurse under the supervision of a GP - will 
improve the service for these patients [20,21]. 
Second, the autonomy of practice assistants will 
increase by delegation of routine tasks from the GP 
to the practice assistant. Increased delegation of 
medical tasks was associated with more successful 
spirometry utilization. Third, the use of protocols in 
practice stimulates systematic working. Fourth, con­
tinuous spirometry education and training should be 
facilitated to maintain standards for GPs, practice 
assistants, and practice nurses [18]. Training of 
practice staff is preferably organized by non-com­
mercial organizations (e.g. GPs' professional orga­
nizations). 
Conclusion and future research 
We conclude that trained GPs with a special interest 
in research, with adequate resources (support staff 
and room space) and in a practice providing 
structured care (protocols), were more likely to use 
spirometry in this study. If a GP lacks these 
conditions, it is essential to improve practice-related 
factors in particular (e.g. presence of a practice 
nurse, delegation of medical tasks to the practice 
assistant, and the use of protocols). This exploratory 
study adds to the current state of knowledge regard­
ing the utilization of spirometry in general practice. 
The next step would be to verify our findings in a 
larger sample of all GPs in the Netherlands as well as 
in other countries, and preferably to measure the 
actual utilization of spirometry by GPs in patients 
with an indication for this particular lung function 
test. 
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Abstract 
Background- Although one out of three general practitioners (GPs) carries out spirometry, the diagnostic interpretation of 
spirometrie test results appears to be a common barrier for GPs towards its routine application. Methods: Multivariate cross-
sectional analysis of a questionnaire survey among 137 GPs who participated in a spirometry evaluation programme in the 
Netherlands. We identified characteristics of GPs and their practice settings associated with GPs' need for ongoing support 
for spirometry interpretation. Results: Response rate on the survey questionnaire was 98%. The need for ongoing support 
among the participating GPs was 69% GPs' recent spirometry training showed a statistically significant association with the 
need for ongoing support for the interpretation of spirometry (odds ratio 0.43, 95% CI 0.20-0.92) 
Conclusion: There is a need for ongoing support for spirometry interpretation among GPs. Recent spirometry training 
partially diminished this need 
Key words: COPD, decision, feedback, general practice, spirometry, support systems 
Introduction 
Chronic obstructive pulmonary disease (COPD) is a 
highly prevalent condition that will contribute to 
global disability for many years to come. Timely and 
adequate diagnosis of the disease in new patients and 
accurate seventy staging in patients who have pre­
viously been diagnosed requires spirometry. Regard­
less of which COPD guideline (1,2) one uses, 
spirometry plays a central role in diagnosing the 
disease, and this requires its widespread implemen­
tation in primary care. However, the mere existence 
of the guidelines does not guarantee that general 
practitioners (GPs) will actually embrace spirometry 
and apply it consistently in the diagnosis and 
management of their patients (3). There are still a 
number of practical barriers that impede implemen­
tation of good-quality spirometry in primary care. 
Examples are the absence of properly trained prac­
tice staff (4), the lack of time and practice support 
(e.g., practice nurses) to fit spirometry into the daily 
practice routine (5), and simply the absence of a 
spirometer in the practice (6,7). 
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In addition to the practical barriers, GPs' lack of 
confidence in their ability to interpret the test results 
(8) is a crucial issue, often completely neglected in 
the guidelines but nonetheless a real impediment to 
effective implementation of spirometry. Low levels of 
self-confidence in the interpretation of spirometrie 
tests influences GPs' interpretative skills (8). Ideally, 
the interpretative skills and confidence levels of GPs 
are supported after appropriate initial spirometry 
training. However, it is largely unknown what kind of 
ongoing support GPs prefer or which factors are 
related to a GP's wish to receive this support. 
Therefore, the aim of the present study was 
to identify characteristics of GPs and their practice 
settings that were associated with GPs' need for 
ongoing support for the interpretation of spirometrie 
tests. 
Methods 
Design and data collection 
We performed a multivariate cross-sectional analy-
sis of questionnaire survey data from 137 GPs 
(Table I) who participated in a spirometry evaluation 
programme in the Netherlands (9) We have re­
ported on the study design, data collection and 
questionnaires used elsewhere (5). In short, all 
GPs involved were sent a questionnaire regarding 
their professional experience, general training level, 
attended continuous medical education, practice 
equipment, bamers to spirometry applications, and 
their need for ongoing support for spirometry 
interpretation. 
Outcomes and analyses 
Potential GP-related and practice-related character­
istics for GPs' need for ongoing spirometry inter­
pretation support (dependent variable) were assessed. 
Because of the clustering of GPs within practices, we 
performed a multilevel logistic regression analysis. 
Multivariate multilevel analyses were applied to 
assess the association between GPs ' need for ongoing 
support and 13 explanatory variables (e.g., type of 
practice, practice nurse support available). GPs' need 
for ongoing support was dichotomized (yes/no ques­
tion). Backward elimination was used to remove 
variables with P > 0 . 0 5 (Table II). The intraclass 
correlation coefficient (ICC) was calculated to give 
insight into the proportion of variance that was 
accounted for by practice level. Also, the fraction 
of explained variance was calculated. Analyses were 
performed in SAS version 8.2 for Windows (SAS 
Institute Inc., Gary, USA, 1999 2001). 
Table I Characteristics of the GPs and general practices involved 
in the study and from national data in the Netherlands (right) 
This study National data 
Values are means (SD), unless stated otherwise 
"Data ( 1 January 2004) from the Netherlands Institute for Health 
Service Research (URL www nivel nl) 
N/A* not available 
Results 
Characteristics of general practices and GPs 
In Table I, we compare certain characteristics of the 
general practices and GPs involved in our study with 
national data. We excluded seven GPs from this 
table due to incomplete data. These seven GPs were 
slightly younger and had less professional experience 
than the remaining 137 GPs. 
Need for ongoing support f or spirometry interpretation 
Ninety-four GPs (69%) expressed a need for on­
going support for spirometry interpretation. The 
most preferred mode of support was either a local 
chest physician or pulmonary function laboratory 
(51%), or a computerized clinical decision support 
system (46%). Clustering of GPs within practices 
accounted for 20.9% of the total variation in GPs' 
need for ongoing support (ICC 0.209). 
Characteristics of GPs and their practice settings 
associated with GPs' need for ongoing support 
Table II shows the results of the multivariate 
analyses. The only practitioner-related factor asso­
ciated with GPs ' need for ongoing support was GP's 
recent spirometry training (odds ratio 0.43, 95% CI 
0.20-0.92). The associations with three other fac­
tors, i.e., availability of different rooms to perform 
spirometry in the practice, some mode of spirometry 
expert support already being in place, and the 
presence of a practice nurse, showed borderline 
statistical significance (P = 0.08, Ρ = 0.09, and P = 
0.15, respectively). The proportion of explained 
variance of this model was 4.1%. 
Discussion 
The results of this study indicate that a majonty of the 
GPs in our study expressed a need for ongoing 
support for spirometry interpretation. Characteristics 
of the practice setting were not associated with the 
need for ongoing support, and characteristics of the 
GP (recent spirometry training) were only marginally 
associated with the need for ongoing support. 
Comparison with previous studies 
This is the first study that has assessed factors 
associated with GPs' need for ongoing support for 
spirometry interpretation among GPs working in 
practices that are already equipped with a spirom­
eter. We assume that, if these GPs already expressed 
a need for ongoing support, other GPs with less 
interest in spirometry would have at least the same 
need for support. 
General practitioners « = 144 Λ — 8209 a 
Age,% < 40 years 25 7 21 
Professional expenence, years 14 3 (Θ 2) N/A 
Gendcr,% female 30 6 3 1 4 
Patients per GP, number 1862 (771) 2392 
per practice 
General practices ; ι = 5 9 Λ"=4564'' 
Type of practice,% 
Single-handed 
Duo 
Group ( > 3 GPs) 
Multidisciplinary healthcare centre 
GPs, number per practice 
Practice assistants, number 
per practice 
Time since introduction of 4 3 (2.9) N/A 
spirometry, years 
33 9 
27 1 
30 5 
8 5 
2 5(1 .4) 
3 1 ( 1 4 ) 
60 7 
26 4 
129 
N/A 
N/A 
27 
Table II Results of the multivariate mululevel analyses 
Explanatory variable 
Reference 
category Odds ratio 
9 5 % confidence 
interval 
GP-related characicnstics 
GPs' professional experience 
Gender 
General interest in scientific research 
Spirometry training pnor to study 
Recent limited spirometry training in study 
Continuous medical education 
Complexity of spirometry interpretation 
Present support for spirometry interpretation 
(c g , feedback from chest physician or computenzed 
expert support) 
Practice-relaied charattensnes 
Type of practice 
Use of protocols in practice 
Practice-nurse support 
Spirometry used in different rooms 
Delegation medical tasks - practice assistants ύ 
Years 
Female 
Non-parucipant 
N o 
Non-attender 
Point on sum score a 
N o 
N o 
0 0 1 3 
- 0 399 
0 095 
- 0 500 
- 0 844 
0 2 1 9 
0 038 
0 7 1 7 
0 58 
0 33 
0 8 1 
0 22 
0 03 
0 57 
0 94 
0 08 
1 01 
0 67 
1 10 
0 6 1 
0 43 
1 24 
1 04 
2 05 
(0 97, 1.06) 
(0 30, 1 50) 
(0 51,2.37) 
(0 27, 1 34) 
(0 20, 0 92) 
(0 58, 2.66) 
(0 36, 2 94) 
(0.92, 4.55) 
N o single-handed 
Point on sum score b 
N o ' 
N o 
% point delegated tasks 
- 0 649 
- 0 251 
0 926 
0 765 
- 0 023 
0 26 
0 30 
0 15 
0 09 
0 11 
0 52 
0 78 
2 52 
2 15 
0 98 
(0.17, 
(0 48, 
(0 72, 
(0.90, 
(1 01, 
1.60) 
125) 
8.83) 
5 14) 
0 95) 
Explained fraction of variance R~ = 4 1% 
"Sum score (range 0-10) of five questions (Likert scale) concerning GP's satisfaction with available time for patients, work, continuous 
medical education, family, and leisure lime 
b S u m score (range 0 4) of five questions (yes = 1, no = 0) w ith regard to the presence of protocols for visiting patients admitted to hospital, 
separate office hours for diabetes care or cardiovascular disease, invitation system for cervical cancer screening, invitation system for annual 
influenza vaccination 
c In Dutch primary care, practice nurses are professionally trained for supporting tasks, predominantly in chronic diseases ( C O P D and 
asthma or diabetes) They work under supervision of a G P They follow stnct protocols for medical care and educate patients They do not 
order additional invesugations They are not allowed to refer patients Nowadays, they are often employed in multidisciplinary healthcare 
centres or group practices 
d I n Dutch primary care, practice assistants are professionally trained for administrative and clinical patient-directed support tasks 
It is important to realise that- like electro­
cardiography spirometry is a complex diagnostic 
tool, at least in the perception of many GPs. A 
systematic approach for judging the quality of tests 
and the subsequent assessment of the relevant lung 
function indices (i.e., FEV,, F E V ^ P / C ) , the ac­
companying predicted values, and the graphical 
output that most electronic spirometers now provide 
(i.e., flow-volume and volume time curves) seems 
difficult. This is clearly illustrated by the results 
of a recent UK study in which low levels of self-
confidence in the interpretation of spirometrie tests 
were observed among 160 general practices that had 
been trained for half a day: only 33% of the practices 
trusted their own interpretative skills with regard to 
spirometry (8). Unfortunately, this kind of very 
limited training is often what GPs commence with. 
Low confidence in the ability to interpret spirometry 
test results was recently reported by Walters et al. 
(V), although these results came from focus-group 
interviews and did not provide insight into GP- and 
practice-related factors. 
Thus far, a New Zealand study, which was reported 
in 1999, presents the only randomized prospective 
evaluation of the implementation of spirometry in 
primary-care practice formally assessing the positive 
impact of limited training on GPs' spirometry per­
formance (10). In our study, a recent limited training 
session diminished the need for ongoing support. 
However, whether a limited training session is suffi­
cient to increase the confidence of GPs in their ability 
to interpret test results seems improbable. 
The problem that still remains is that lack of 
expertise in spirometry testing seems to be the limit­
ing factor for its routine application in general 
practice (4,5,7,8). This has clinical repercussions, 
with misclassification occurring in one out of three 
patients with a clinical diagnosis of COPD in primary 
care as a result (8). Therefore, the interpretative skills 
of GPs are ideally supported after an initial spirome­
try training programme. However, the results of our 
study and the current literature (7,8) do not give 
enough insight into which GPs in which practice 
settings will benefit most from ongoing support nor 
do they help us in deciding which mode of organizing 
this support would be best. This ongoing support 
could be organized by a fellow GP with a special 
interest in respiratory diseases in their own practice 
or in another practice nearby ( 11 ), by a computerized 
clinical decision support system (12), or by consulta­
tion or feedback from a chest physician (13). 
Empirical studies on the effect of this kind of ongoing 
expert support on the interpretative capacity of 
pnmary-care doctors are not available at this time 
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Limitations of the study 
A weakness of our study is the external validity. Due 
to selective participation of GPs who wanted to 
participate in a spirometry research project and the 
fact that—compared with national data—we in-
cluded a relatively small proportion of single-handed 
practices, our findings may not fully reflect the 
situation in Dutch general practice. Despite the 
fact that we investigated 13 plausible characteristics 
concerning the GP and his/her practice setting, we 
were not able to predict the need for ongoing 
spirometry interpretation support with this model 
adequately. Our model explained only 4 .1% of all 
variance in the dependent variable. Apparently, there 
are other factors that influence GPs' need for 
ongoing support that have not been investigated in 
the questionnaires. Qualitative studies (e.g., in-
depth or focus-group interviews) are required to 
further address this issue (14). 
Possible implications for future research 
If GPs do not perform spirometry in their own 
practice due to insufficient expertise in the inter-
pretation of results, the number of patients referred 
for spirometry testing may soon exceed the capacity 
of secondary care. From the current study, we know 
that a recent spirometry training session is not 
enough to decrease the need for ongoing support 
for spirometry interpretation. 
As spirometry does indeed seem to influence the 
decision-making process of GPs (15), the focus on 
COPD in primary care should be directed at 
increasing the confidence of GPs in their ability to 
interpret spirometry test results. 
Conclusions 
We conclude that most (~70%) GPs who were 
already equipped to use spirometry in terms of 
training and facilities expressed a need for ongoing 
spirometry interpretation support. Recent spirome-
try training partially diminished this need, but 
ongoing support for the interpretation of spirometry 
tests in primary care certainly seems welcome. GPs' 
need for ongoing support for spirometry interpreta-
tion could only marginally be explained by the 
characteristics of GPs and their practice settings. 
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Spirometry in chronic obstructive pulmonary 
disease 
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Spirometry in chronic obstructive pulmonary 
disease 
Is available, yet underused in general practice 
Chronic obstructive pulmonal") disease aficcts about 1"/) ot the total LK population1 and is a majoi cause oi disabihu and moriahtv 
worldwide l imeh diagnosis and subsequent staging of 
se\cnt\ of disease both requite spirometrv which in 
theorv can be performed by trained general pnutition 
ers (GPs) «md their practice staff However, numeious 
barriers impede the implemenution oi spnomeh) in 
pnman care 
Several guidelines exist foi the management of 
pauenis with chiome obstructive pulmonan disease 
including üiose fiom the LK Nauonal Instituie tor 
Health and Clinical excellence (MCE)* and the Global 
Initiauve foi Chronic Obstructive Lung Disease 
(OOI D www goldcopdcom) All guidelines stress die 
central role of spirometrv in diagnosing and managing 
the disease in pnman care but this does nol guarantee 
that GPs will use this technique consistcntlv in the caie 
of patients w ith rcspiraton swnptoms 
Sevei"a] models to provide spirometr) test results 
exist, depending on local circumstances, these include 
regional pnmar) care diagnostic services and hospital 
based lung function laboratones with open access for 
pnman care patients However the most practical and 
timel) solution is for GPs to have iheir own spirometer 
in die practice In the Lmled Kingdom about 80 Vt of 
general practices own a spirometer" but these 
instruments aie still scarce in large parts of the woild. 
32 
even though prices have dropped considerably in the 
past few years. Trained practice stati' who have the skills 
and time to fil and maintain spirometry of suÌTÌcicnt 
quality imo the daily practice routine'1 may also be in 
short supply."' In addition to the practical issues, GPs' 
lack of confidence in their ability to intcrpiet the lest 
results is a cruciai barrier—often neglected in the 
guidelines to effective implementation of spii omeiry." 
Many GPs view spirometry as a complex diagnostic 
tool, like electrocardiography. This fact was clearly 
illustrated in a recenl UK. study that leported low levels 
of self confidence in interpreung spiiometric tests in 
160 general practices where GPs and nurses had been 
trained foi halt a day—only a thiid of these profession-
als trusted their own interpretative skills." Confidence 
about how to proceed once the test results are available 
is a crucial pail of building GPs' confidence in theii 
capacity to diagnose and manage the disease. 
Ideally once GPs have had initial spirometry tiain-
ing they should receive continuous advice and support. 
This could be done in various ways—by another GP 
with a special interest in respiratory diseases in the 
same practice or in another practice nearby; by means 
of a computerised clinical decision support system 
(SpidaXpert softwaie; w^-vv.spirxpert.com); or by 
consultation or feedback from a chest physician. 
Although intuitively a promising idea, empirical 
studies on the effects of ongoing expert support on the 
interpretative capacity and self confidence of GPs are 
lacking. 
So what needs to happen next? For guidelines on 
chronic obstructive pulmonary disease to be imple-
mented, concrete working agreements between GPs 
and chest physicians need to be developed. Chest phy-
sicians tan act as coaches for their local primary caie 
colleagues in two ways—through patient oriented sup-
port (specific feedback for specific patients) or through 
practice oriented support (as teachers in postgraduate 
training programmes). This will be beneficial for both 
parties, as referrals will be moie structured and based 
on agreed criteria, GPs who have performed 
spirometry will have better insight into the patient's 
lung function, and chest physicians will benefit from 
having the results at the initial consultation." More 
broadly, coordinated efTorts by health policy makers 
and the medical profession will be needed lo provide 
the right equipment, training for staff who use it, and 
continuing quality assurance and support for test 
interpretation. The burden of chronic obstructive pul-
monary disease is sufTiciently large to warrant such an 
approach. 
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general practitioners' decision making 
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ABSTRACT The present study assessed the impact of computerised spirometry interpretation 
expert support on the diagnostic achievements of general practitioners (GPs), and on GPs' 
decision making in diagnosing chronic respiratory disease. 
A cluster-randomised controlled trial was performed in 78 GPs who each completed 10 
standardised paper case descriptions. Intervention consisted of support for GPs' spirometry 
interpretation either by an expert system (expert support group) or by sham information (control 
group). Agreement of GPs' diagnoses was compared with an expert panel judgement, which 
served as the primary outcome. Secondary outcomes were: additional diagnostic test rates; width 
of differential diagnosis; certainty of diagnosis; estimated severity of disease; referral rate; and 
medication or nonmedication changes. Effects were expressed as odds ratios (ORs) with 95% 
confidence intervals (CIs). 
There were no differences between the expert support and control groups In the agreement 
between GPs and expert panel diagnosis of chronic obstructive pulmonary disease (OR (95% CI) 
1.08 (0.70-1.66)), asthma (1.13 (0.70-1.80)), and absence of respiratory disease (1.32 (0.61-2.86)). 
A higher rate of additional diagnostic tests was observed in the expert support group (2.5 (1.17-
5.35)). 
Computerised spirometry expert support had no detectable benefit on general practitioners' 
diagnostic achievements and the decision-making process when diagnosing chronic respiratory 
disease. 
KEYWORDS Computer-assisted diagnosis, expert systems, family practice, spirometry 
A lthough all major chronic obstructne pulmonary disease (COI'D) guidelines stress the central role of spirometry in 
diagnosing and managing chronic respiratory 
disease [1,2], this does not guarantee that general 
practitioners (GPs) will consequently use spiro­
metry in the care of their patients with respira­
tory symptoms [3, 4] 
Most common barriers that impede utilisation of 
spirometry in general practice are the absence of 
properly trained staff [5], the lack of time and 
practice support to fit spirometry into the daily 
practice routine [6], the absence of a spirometer in 
the practice [7], and GPs' lack of confidence in the 
ability to interpret the test results [8, 9] A recent 
s u n e y [4] showed that one third of Australian 
GPs interpreted less than one spirometry test per 
week Due to this low pre\alence of test inter­
pretations, it seems difficult for GPs to become 
experts in this area 
The present authors ha\e prewously demon­
strated the influence of spirometry on GPs' 
diagnostic achievements and management deci­
sions in a nonrandomised simulation study [10] 
Other recent nonrandomised studies [11,12] con­
firm that spirometry increases diagnostic rates of 
chronic respiratory disease and may lead to 
management changes in a general practice 
population Howe\er, an absolute prerequisite 
for the use of spirometry is the validity (or 
reliability) of spirometrie tests In a previous 
study with patients with COPD, ScHi-R\iER el al 
[13] observed that the most relevant indices, as 
measured by trained general practice staff, were 
comparable with those measured in pulmonary 
function laboratories 
Therefore, once GPs ha\e had initial spirometry 
training and spirometry equipment and test 
\aliditv are adequate, the next step to improve 
implementation of spirometry in general practice 
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is to arrange for the possibility to receive continuous advice 
and support for test interpretation [14] This could be carried 
out by means of a diagnostic computerised clinical decision 
support system [15,16] While there is already such an expert 
support system available on the market [17] and GPs welcome 
such type of support [18], empirical studies on the effects of 
ongoing expert support on the interpretative capacity and self-
confidence of GPs are warranted 
The objective of the present study was to assess the impact of 
expert support for the interpretation of spirometry tests on 
GPs' diagnostic achievements and decision-making processes 
when diagnosing chronic respiratory disease 
METHODS 
Study design 
The study was a simulated cluster-randomised trial of GPs' 
diagnostic acuity of chronic respiratory disease in a process of 
diagnostic assessment of 10 standardised cases, with an expert 
system support A diagnosis of the cases by the expert panel 
served as the gold standard Differences in GPs' diagnostic 
achievements and decision-making processes were compared 
both between the study groups and within groups 
Ethical approval 
The present study was approved by the Medical Ethics Re\ lew 
Board of the academic hospital Radboud University Nijmegen 
Medical Centre, Nijmegen, the Netherlands 
Participants 
GPs from the catchment area of the Radboud University 
Nijmegen Medical Centre and from a specific general practice 
network of the present authors' department at this hospital [19] 
were invited to participate by postal mailing 
Intervention 
GPs were randomly allocated to one of the following two 
groups 1) the computerised spirometry expert interpretation 
support group, and 2) the control group GPs in the expert 
support group received the spirometry test results, the flow-
volume curve, and the graphical interpretation and textual 
interpretative notes GPs in the control group received the 
spirometry test results, and the flow-volume and volume-time 
curves (fig 1) 
The spirometry expert system (SpidaXperU, Micro Medical 
Ltd, Rochester, UK) [17] contains a diagnostic algorithm based 
on pre- and post-bronchodilator forced expiratory volume in 
one second (FEVi)/forced vital capacity (FVC) and FEVi 
values and the accompanying age, sex and ethnicity-specific 
predicted values The expert interpretation module in 
SpidaXpertn had been developed with funding of the 
Netherlands Asthma Foundation by a group of independent 
experts [17] The spirometry interpretation is presented as 
coloured bars that indicate levels of FEVi/FVC and FEVi, and 
compares the values before and after bronchodilatation The 
graphical representation is further elucidated by a textual 
interpretation, which provides information on and suggestions 
for additional diagnostic testing and treatment options 
GPs in the control group received the volume-time curve as 
sham information Sham information was introduced in the 
control group to be able to compare GPs reassessment of a 
diagnosis in the control group in the same way as in the expert 
support group Sham information has, in fact, a placebo effect, 
as no new data was being presented to these GPs, earlier data 
(j e the flow-volume curve) was presented in each case again 
but in another way, / e the \olume-time curve Although it is 
clearly important to e\aluate the quality of forced expiratory 
manoeuvres, ι e end-of-test criteria [20], the volume-time 
curve does not add relevant new information from a diagnostic 
point of view to the information pro\ ided by the flow-\ olume 
curve and the numerical test results Prior to the study, 
participants were informed that they would receive additional 
information on spirometry and were asked to reconsider their 
diagnosis No further specification was given of the nature or 
the background of that information 
Standardised case descriptions and gold standard 
Based on the present authors' experiences in a previous study 
[10], it was known beforehand that GPs are quite able to 
diagnose common respiratory disease patterns, whereas rare 
pathologies and inadequate test results are more difficult for 
them to recognise Furthermore, the challenge to differentiate 
COPD from other conditions that result in respiratory 
symptoms {eg heart failure, asthma) grows with the age of 
the patient This was the reason for including case descriptions 
of adult patients only, with a special focus on the 50-60-yr-old 
age group This category reflects daily practice patterns in 
primary care The case descriptions, in which a GP would use 
spirometry as a diagnostic test, were as follows COPD 
(classified as Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) stage I (n = l), stage II (n-1) and stage III 
(n=2)) [2], asthma (n=2), allergic asthma (n = l), lung fibrosis 
(n = l), no respiratory disease (n=l), incorrect test manoeuvre 
(n = l), and exercise-induced asthma (n-1, see supplementary 
material for example case) 
At inclusion, a research assistant visited the participating GPs 
in their practice During a 90-min audiotaped session, an 
example case and 10 standardised cases were presented on a 
laptop computer using PowerPoint slides GPs worked 
through the cases in a random order GPs first practised on 
one separate example case to become familiar with case 
structure For each case, a concise medical history, the results 
of physical examination and the medication were presented to 
the GP first Subsequently, absolute predicted pre- and post-
bronchodilator spirometry test results (including FEVi FVC, 
FEVi /FVC and flow-volume curv es) were provided GPs were 
asked to consider their diagnosis and management before the 
upcoming intervention Next, GPs received additional infor­
mation next to the spirometry test results either the graphical 
representation of FEVi, FEVi/FVC together with interpretative 
notes (expert support group) or the volume-time curve 
(control group) Again GPs were asked to reconsider their 
diagnosis and management after the interv ention An example 
of the case structure is depicted in figure 2 Due to time 
limitations, the present authors requested only for specific 
medication and nonmedication changes after the intervention 
in cases with already diagnosed respiratory disease (six out of 
10 cases) 
Before their use in the study, the cases were judged by an 
expert panel consisting of two chest physicians, a GP (PJ Ρ 
Poels) with specific expertise in spirometry and a health 
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Recruitment of participants 
(n=112GPs) 
Random allocation 
of GPs (n=78) 
Expert support group 
(n=36 GPs) 
All GPs received allocated intervention 
GPs working diagnosis (360 cases) 
COPD 165 
Asthma 107 
Lung fibrosis 7 
Absence of respiratory disease 19 
Other diagnoses 62 
Diagnostic 
assessment 
before 
intervention 
Spirometry test results 
Pre- and post-BD FEVi FVC, FEVi/FVC% 
Post-BD % predicted FEVi and FVC 
Flow-volume curve 
Plus 
Information from expert system, 
Graphical interpretation results 
Textual interpretation results 
Intervention 
GPs working diagnosis (360 cases) 
COPD 164 
Asthma 114 
Lung fibrosis 3 
Absence of respiratory disease 21 
Incorrect test 21 
Other diagnoses 37 
Diagnostic 
reassessment 
after 
intervention 
Analysed (357 cases) 
Excluded from analysis (3 cases)" Analysis 
Nol interested (n=34 GPs) 
Control group 
(n=42 GPs) 
All GPs received allocated intervention 
GPs working diagnosis (420 cases) 
COPD 184 
Asthma 125 
Lung fibrosis 1 
Absence of respiratory disease 25 
Olher diagnoses 85 
Spirometry lest results 
Pre- and post-BD FEVi FVC FEVi/FVC% 
Post-BD % predicted FEVi and FVC 
Flow-volume curve 
Plus 
Sham information 
Volume-time curve 
GPs working diagnosis (420 cases) 
COPD 180 
Asthma 123 
Lung fibrosis 1 
Absence of respiratory disease 23 
Incorrect test 28 
Other diagnoses 65 
Analysed (417 cases) 
Excluded from analysis (3 cases)* 
FIGURE 1 . Participanls to Ihe presenl sludy and miervention GP general praclilioner COPD chronic obstruclive pulmonary disease BD bronchodilalalion FEVi 
lorced expiratory volume in one second FVC lorced vilal capacity " the first six GPs used an example case with an expen panel s diagnosis ot absence ol respiratory 
disease and a test case ot exercise asthma For the other 72 consecutive GPs Ihe case sel was switched between these two cases the case ot absence ol respiratory 
disease was included lor them in the linai case sel Therefore mlormalion was not available Irom the first six GPs about the case ol absence of respiratory disease equally 
divided among expert support (n-3 GPs) and control group (n=3GPs) 
scientist (TRJ Schermer) The panel consensus diagnoses 
served as the gold standard in the subsequent evaluation of 
GPs' diagnostic achievements 
The whole approach was piloted in four GPs before the start of 
the study Shortly after the first six study visits, the case set 
was adjusted by switching the example case with a case out of 
the actual set As a result, no data of the new introduced case 
were available for those first six GPs (equally divided over the 
two groups) 
Primary and secondary outcome measures 
The difference between the percentage agreement of the cases' 
diagnoses between GPs and expert panel judgement before 
and after interpretation of spirometry served as the primary 
outcome Diagnoses were directed to the following five 
outcome categories 1) COPD, 2) asthma, 3) rare respiratory 
pathology (lung fibrosis), 4) absence of respiratory disease, and 
5) incorrect test manoeuvre 
Six predefined secondary outcome measures were assessed 
using indicators that show the impact of the expert system 
intervention on the GPs decision-making processes, as follows 
1) probability of ordering additional diagnostic tests (yes/no), 
2) width of the differential diagnoses (ic the working 
diagnosis plus the number of alternative diagnoses considered 
by the GP), 3) a GP's certainty of the working diagnosis (self 
scored 0-10, with 0=uncertain and 10=certain), 4) a GP's 
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Medical history 
Male 56yrsold 
dyspnoea with 
exercise for 1 5 yrs 
former smoker 
Physical examination 
Normal pulmonary auscultation 
no cardiac abnormalities 
blood pressure 150/90 mmHg 
Medication 
Metoprolol 50 mg 
Pulmicort 400 meg 
Pantozol 40 mg 
(all once daily) 
Spirometry test results 
- _ 
VokmL 
bpiometne 
pnBD 
FEVl (Lf 2 SI 
FT/C(L)- <5β 
FEVlSffHC 64 
poUBO pvedktid 
318 [3 75 
51 r4 74 
a 
EGKS/EHS . 
Pod BD V 
p r x J c M 
6 5 % 
1 0 9 % 
Qu«*» 
Intervention 
Expert support group-«- -*• Control group 
Pori BO % 
in BO pa« BD pndctid prtdcM 
FEVIflJ 2W 319 375 
fVClLI <5B s i i n 
Ψ" 
Interpretation mild obstruction 
FEVi within normal range 
Pad BO ΐ 
m BD MBO pndktid prMnu 
FtVI lL l 2S4 31β Î 75 fl6 % 
IFMTILl I M 51 171 m * 
Before Intervention, GPs asked to consider 
Diagnosis and differential diagnosis7 
Additional diagnostic tests and referral'' 
Certainty of diagnosis' 
Seventy of diagnosis? 
After intervention, GPs asked to consider 
Diagnosis and differential diagnosis7 
Additional diagnostic tests and referral 
Certainty of diagnosis7 
Severity of diagnosis7 
Medication or nonmedtcation changes 
(optional question in six cases) 
F IGURE 2. Schematic representation ol a case structure detailing inlormalion presented to Ihe general practitioner (GP) and points ol consideration 
BD bronchodilalation FEVi lorced expiratory volume in one second 
perception of seventy of the working diagnosis (self-scored 
0-10 with 0-no se\ere disease and 10=severe disease), 
5) probability of referral to secondary care (yes/no), and 
6) probability of medication and nonmedication changes 
Medication change included stopping or lowering treatment 
with inhaled corticosteroids or bronchodilators, the com-
mencement of bronchodilator, inhaled or oral corticosteroid 
treatment, or combination drug treatment Nonmedication 
included giwng smoking cessation advice 
Sample size 
Calculation of the sample si7e was based on an estimated 
relevant proporhon of correctly interpreted cases after spiro-
metry expert support of 25% compared with no expert 
support Assuming a correctly interpreted proportion of cases 
without support of 50% [5], 1=0 05, a power of 80% and an 
intra-cluster correlation r=0 18, 31 GPs were required in each 
randomisation group To allow for dropouts and subgroup 
analyses, the aim was to include >70 GPs 
Random/sat/on 
The research assistant used restricted randomisation (mini-
misation) with a computer program on a laptop computer 
using the following three stratification factors 1) a GP s prior 
experience with the specific computerised spirometry inter-
pretation support package (yes/no) 2) the average number of 
spirometry tests a GP reported to interpret per week, and 3) a 
GP's experience (in years) with spirometry The researchers 
and the statistician (R Ρ Akkermans) were blinded while 
assessing and reporting all outcomes 
Statistical analysis 
Agreement between GPs' and expert panel judgement was 
expressed as percentages with 95% confidence intervals (CIs) 
Multilevel regression logistic modelling was used to account for 
the intracluster correlation induced by the fact that each GP 
assessed more than one case, and the fact that the same cases 
were applied repeatedly in different GPs Multile\el logic 
analyses were performed for dichotomous variables and multi­
level regression analyses for continuous variables Odds ratios 
(ORs) with 95% CIs were calculated to evaluate differences in 
percentages of agreement before and after the intervention with 
the expert judgement between the study groups Sensitivity, 
specificity, positive and negative predictive values (PPV and 
NPV, respectively), and the diagnostic OR (DOR) [21] with 95% 
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Cis were calculated for GP judgements of COPD, asthma, rare 
respiratory pathology and no respiratory disease after the 
intervention. ORs with 95% CIs were also used to evaluate 
differences in indicators GPs' decision-making process. 
To detect possible effect modifications before intervention, 
subgroup analyses were performed for a GP's prior experience 
with spirometry, a GP's prior experience with expert support 
and a GP's number of interpreted spirometry tests per week. 
RESULTS 
Baseline characteristics of GPs 
Between January and October 2006, 78 GPs were enrolled in 
the present study; 36 were allocated to the expert support 
group and 42 to the control group (fig. 1). All GPs completed 
the study. Relevant characteristics at baseline were similar 
between the two groups (table 1). 
Primary outcome: diagnostic achievements by GPs 
GPs assessed a total of 774 cases, 357 cases from the expert 
support group and 417 cases from the control group. There 
was no difference between the expert support and control 
group in agreement on judgement between GPs and the expert 
panel for presence of COPD, asthma, absence of respiratory 
disease and incorrect test manoeuvre after intervention 
(table 2). GPs' agreement with the expert panel for all cases, 
except the incorrect test manoeuvre case, was 66.0 (expert 
support) versus 65.97« (control) before intervention and 68.5 
(expert support) versus 63.5% (control) after intervention. 
Although the DORs in the expert support group were 
consistently higher than in the control group, no significant 
differences were found between the groups (table 3). GPs did 
not recognise an incorrect test manoeuvre in 28.6% (in both 
expert support and control groups) of cases. The highest NPVs 
were found for cases with the conditions of asthma and 
absence of respiratory disease. 
Secondary outcomes; indicators of GPs' decision-making 
process 
GPs in the expert support group ordered slightly more 
additional diagnostic tests compared with the control group 
(OR (95% CI) 2.5 (1.2-5.4); table 4). There were no significant 
I Baseline characteristics of all randomised general 
GPs η 
Type of practice 
Single handed 
Duo 
Group (s3 GPs) 
Multidisciplinary healthcare centre 
Male% 
GP's experience with spirometry in yrs 
Spirometry results interpreted per week 
Prior experience with expert support % yes 
Data are presented as η {%) or mean±SD unless otherwise indicated 
differences between the two groups for other secondary 
outcome measures. There were also no specific changes (start, 
stop or lower) in medication (bronchodilators, inhaled steroids 
or nonpulmonary drugs) between the study groups. 
Subgroup analyses 
Neither a GP's experience with spirometry (OR (95% CI) 1.02 
(0.97-1.06)), nor a GP's prior experience with expert support 
(0.97 (0.72-1.31)) or a GP's number of interpreted spirometry 
tests per week (1.02 (0.84-1.23)) was associated with the 
effectiveness of expert support, as their agreement with the 
expert panel was not different before intervention. If GPs 
interpreted more spirometry tests per week and had prior 
experience of expert support, the probability of agreement 
with the expert panel before intervention increased; however, 
this probability decreased if GPs had no prior experience with 
expert support (interaction effect p=0.02). 
DISCUSSION 
Statement of principal findings 
Computerised spirometry expert support for the interpretation 
of spirometry tests by GPs had no detectable benefit over sham 
information on GPs' diagnostic achievements of chronic 
respiratory disease. Overall, expert support did not influence 
GPs' decision-making processes. 
Strengths of the study 
The present study is the first diagnostic study to assess the 
impact of a commercially available computerised expert 
support system for spirometry in a randomised simulation 
study in primary care. The study used standardised patients, 
which meant that all participants were faced with the same 
diagnostic challenges. This could only be achieved in an in 
vitro design, as the mix of practice patients in real life would 
make it difficult to capture the necessary variation in 
diagnostic challenges. 
The standardised complex and original method that was used 
to assess the impact of expert support in the present study has 
been used before in a nonrandomised design [10]. Based on 
previous information [10], the present authors were able to 
create a balanced mixture of cases relevant for GPs. 
The confirmative role of spirometry was more strongly 
Expert support group 
36 
2(5) 
9(25) 
15 (42) 
10 (28) 
64 
5.5±43 
1 4 + 08 
47 
Control group 
42 
4(10) 
9(21) 
19 (45) 
10 (24) 
57 
6 3±3.3 
1 4+07 
36 
40 
Agreement on case diagnoses between general practitioners (GPs) and expert panel judgement betöre and after 
intervention 
GP diagnosis 
Presence of 
COPD 
Aslhma 
Flare respiralory palhology 
Absence of respiralofy disease 
Incorrect tesi manoeuvre 
Expert support group* 
Before 
32 5 
23 5 
0 6 
2B 
NA 
AHer 
32 5 
25 2 
0 3 
3 6 
5 9 
Control 
Before 
32 4 
23 5 
0 0 
3 Ί 
NA 
group' 
After 
30 7 
23 0 
0 0 
1 4 
6 71 
Expert panel 
40 
30 
10 
10 
10 
OR* (95% CI) 
1 08 (0 70-1 66) 
1 1 3 ( 0 70-1 80) 
NA 
1 32 (0 61 2 86) 
0 87 (0 48-1 56) 
Dala are presented as % unless otherwise indicated OR odds ratio CI confidence interval COPD chronic obstructive pulmonary disease NA not available * n=357 
' n=417 + ORs express the difference in GPs judgemenl before and after intervention ie expert support compared with control 
focussed on than the exclusne role of spirometry in primary 
care To avoid bias, cases were presented in a (computer-
generated) random order and analyses were performed 
blinded for both the investigators and the statistician 
Subgroup analyses showed no difference in baseline diagnostic 
achievements of GPs with prior experience of spirometry or of 
the expert support system used, and on the number of 
spirometry tests a GP interpreted per week Therefore, the 
external validity seems quite good, given the fact that the 
participants were not specifically interested in spirometry 
Possible limitations 
The present trial has some limitations In a diagnostic 
assessment of chronic respiratory disease, a GP's consideration 
to perform spirometry in case of an intermediate prior 
probability of disease is a great diagnostic step [21] This step 
was already foreseen in the present studv design The next step 
of diagnostic refinement does not seem to influence extensi\ ely 
the posterior probability In the present study, the diagnostic 
achievements of GPs in both groups were high (prior 
probability of a correct diagnosis was — 66%) Overall, only 
4 3% of initial diagnoses changed after intervention As the 
posterior probability in both groups was nearly the same as the 
prior probability, the role for expert support to change 
diagnosis and management was \erv small Furthermore, the 
diagnostic achievements of the GPs exceeded the present 
authors' assumptions in the power calculation (50% correct 
diagnoses without expert support) It is probable that instruc­
tion and support for these GPs had not been effective, as these 
Sensitivity, specificity, predictive values and diagnostic odds ratios (ORs) for general practitioners' judgement after 
intervention 
COPD 
80 6 
77 5 
70 7 
85 5 
142 
8 46 23 98 
76 2 
79 1 
71 1 
8 3 1 
121 
7 60-19 34 
0 6 5 
Asthma 
83 3 
9 0 4 
78 9 
92 6 
46 9 
24 35 90 23 
76 2 
9 0 7 
78 0 
89 8 
3 1 3 
17 73 55 22 
0 36 
Rare respiratory 
pathology 
2 8 
99 4 
33 3 
9 0 1 
4 6 
0 59-35 90 
0 0 
99 7 
0 0 
89 9 
NA 
0 0-34 79 
NA 
Absence of respiratory 
disease 
39 4 
97 5 
6 1 9 
94 0 
25 7 
9 74-67 71 
35 9 
97 6 
6 0 9 
93 7 
23 0 
9 22-57 17 
0 87 
Expert support group 
Sensitivity 
Specificity 
PPV 
NPV 
Diagnostic OR 
95% CI 
Control group 
Sensitivity 
Specificity 
PPV 
NPV 
Diagnostic OR 
95% CI 
p-value 
Data are presented as % unless otherwise indicated COPD chronic obstructive pulmonary disease PPV positive predictive value NPV negative predictive value 
CI confidence interval NA not available 
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Impact of the intervention on six indicators of general practitioners' (GPs) decision-making process 
Indicators Expert support group' Control group' OR (95% CI) 
Additional diagnostic tests 
Radiographic imaging 
Blood tests 
Lung function 
Prednisone course 
Electrocardiography 
Other' 
Width of dllferential diagnoses 
Certainty of diagnosis 
Perception of severity of diagnosis 
Referral rate 
Medication and nonmedicatlon changes 
% y e s 
Stop or lower medication 
Inhaled corticosteroids 
Bronchodilators 
Start medication 
Short-acting bronchodilators 
Long-acting bronchodilators 
Inhaled corticosteroids 
Oral corticosteroids 
Combinational drug 
Nonmedicatlon changes 
Smoking cessation advice 
Before 
70 2 
4Θ7 
2 9 2 
132 
11 2 
3 6 
1 1 
2 2 + t 0 
6 8 ± 2 0 
6 0 ± 2 2 
186 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
After 
5 2 
0 9 
0 9 
2 3 
2 6 
0 3 
0 0 
1 7 + 0 9 
7.1 ± 1 9 
5 9 ± 2 3 
1 7 
76 2 
102 
0 9 
26 9 
153 
3 1 0 
6 5 
3 7 
30 1 
Before 
75 3 
51 3 
39 1 
1 5 2 
8 9 
6 0 
0 7 
2 3 ± 1 0 
7 3 ± 1 9 
6 3 ± 2 1 
178 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
After 
3 0 
0 8 
1 3 
0 3 
1 0 
0 2 
0 0 
1 7 ± 1 , 0 
7 3 ± 1 8 
6 3 ± 2 1 
2 5 
69 1 
6 3 
0 8 
22 2 
155 
31 0 
5 6 
2 8 
3 3 7 
2 5 ( 1 17-5 35)* 
1.27(025-6 41) 
1.0(0 65-1 55) 
1 0 (0 59-1 70) 
1 0 ( 0 61-1 63) 
1 0 ( 0 55-180) 
NA 
10(0.81-1 19) 
1 0 (0 57-1 43) 
1 0 (0 57- 1 42) 
1 0 (0 60-1 66) 
1 44 (0 80-2 59) 
1 67 (0 85-3 28) 
1 17(0 16-8 40) 
1 27 (0 73-2 20) 
1 01 (0 46-2 18) 
1 00 (0 68 1 49) 
1 34 (0 44-4 10) 
1 2 7 ( 0 26-8 19) 
0 85 (0 57 1 26) 
Data are presented as % or mean±SD unless otherwise indicated OR odds ratio. Ct conlidence interval NA not available * n=357: ' n-417 + ORs express the 
difference in an indicator of the GPs' decision-making process before and after the intervention, ι e expert support compared with control * includes urine test 
gastroscopy ergometry blood pressure temperature and oxygen saturation ' this information was available for six out of 10 cases (expert support η = 216 control group 
n=252 cases) * p<0 05 
GPs could already be considered experts due to prior 
participation in other studies or postgraduate spirometry 
training programmes from the present authors' department. 
Therefore, the expert system had hardly additional value and 
could be considered a "sort of luxury appendix" for these GPs. 
A large within-group difference was found for ordering 
additional diagnostic tests, which may be an effect of the 
study design: GPs barely reassessed their diagnostics after 
intervention, because they expected the results of their 
diagnostics to have been already discounted before interven­
tion. However, the objective was to reassess the opinion of GPs 
when new information, i.e. expert support, was available, 
regardless of their earlier assessment in the same case. 
From a methodological point of view, the use of the volume-
time curve as sham information could be questioned. 
Theoretically, such curves do not show new information to 
GPs after presentation of the flow-volume curves. 
Additionally, this is not really "usual care", as most GPs in 
the Netherlands are trained to look at flow-volume curves 
rather than volume-time curves. Conversely, the volume-time 
curve is much more intuitive and may have improved 
unconscious performance of spirometry interpretation in the 
control group. Furthermore, providing the expert panel and 
GPs in the present study with a fixed cut-off value of <0.7, 
instead of the lower limit of normal for the FEVl/FVC ratio in 
the standardised cases may have led to an overestimation of 
diagnosed airflow obstruction [22]. Further discussion about 
the pros and cons of using a fixed cut-off value Oersus the lower 
limit of normal for FFVl/FVC [23] is bevond the scope of the 
present paper. 
Finally, a possible reason why no differences could be 
demonstrated in diagnostic achievements should be sought 
in the expert support system used. Although the expert 
support system used in the present study met the criteria of 
a good system \\5], i.e. involvement of the present authors by 
development, integration through the computer, and the 
displaying of specific recommendations at the right place 
and time, it was not actually tested in the target group, i.e. GPs, 
before the study. Therefore, it may not optimally comply with 
the decision-making process of GPs. The information pre­
sented by the system to the GP possibly lacked explanation of 
exactly what the output means. These are known barriers to 
the adoption of expert support in primary care [24]. 
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Relation to other studies 
A recent systematic review [16] demonstrated the following 
two relevant issues with respect to expert support systems 
1) the effects of diagnostic expert support systems on GPs' 
performance were low, and 2) trials evaluating diagnostic 
systems were scarce Currently, there are no similar expert 
support studies available with which to directly compare the 
present results It is important to realise that, similarly to ECG, 
spirometry is a highly complex diagnostic tool in the 
perception of many GPs Although a recent study evaluating 
the ECG interpretation skills of GPs and the value of automatic 
ECG recorded interpretations [25] seemed promising to 
compare the present study's results with, it lacked the correct 
design In the present study, and similarly to the results of the 
study by JI-NSCN et al [25], the PPVs were lower than the NPVs 
The highest NPVs were found for the cases with the conditions 
of asthma and absence of respiratory disease This probably 
reflects the fact that it is more difficult for a GP to confirm the 
presence of a disease than to exclude its presence 
The acuity of GPs' interpretation of test results has been 
evaluated by others In 1999, EATON cl ai [5] had already found 
that 53% of GPs' interpretation of spirometry test results was 
]udged to be correct according to an expert panel Recently, 
RACHUNATH et al [9] found that the agreement in interpretation 
of spirometry and peak flow results between nurses, GPs and an 
expert panel was only 20% The lower agreement in the latter 
study could probably be explained by the fact that GPs, as well 
as nurses, ; e less-trained professionals, assessed a common 
diagnosis Furthermore, contrary to GPs and nurses, the expert 
panel did not have detailed clinical history information to assess 
their final diagnosis on and, due to a design artefact, 
interpretation of their study results was difficult Results of 
the present study concur with the results of EATON et al [5] and 
show that, generally, GPs have made progress in the interpreta­
tion of test results relevant for respiratory diseases in primary 
care The current acuity of GPs' interpretation of test results 
should weaken earlier reported lack of confidence in the ability 
to interpret the test results [8, 9] 
Unanswered questions and future research 
Generally, two questions remain to be answered 1) how can 
optimal quality spirometry results in primary care be achieved 
outside of research settings', and 2) what is the most effective 
way to give continuous expert support for the interpretation of 
spirometry test results, given a situation of optimal quality 
results [14]' Continuous expert support could be provided by 
means of consultation or feedback from a chest physician or by 
means of an expert support system The results of the present 
study add to current knowledge that computerised spirometry 
expert support had no detectable benefit over sham informa­
tion on GPs' diagnostic achievements and decision-making 
processes when diagnosing chronic respiratory disease The 
comparison of support from a chest physician versus compu­
terised expert support for spirometry test results calls for 
further study 
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Abstract 
Background This study assessed the impact of two modes of expert support for the 
interpretation of spirometry tests on the diagnoses as established by general 
practitioners (GPs) and their subsequent management decisions in patients with, or 
suspect for chronic respiratory disease 
Methods We performed a cluster-randomised controlled trial with general practices 
as unit of randomisation GPs from 44 Dutch general practices recorded their 
diagnosis and (planned) management before and after a spirometry test and 
interpretation for 868 patients with (possible) respiratory conditions in which 
spirometry plays a role in the diagnostic work-up Intervention consisted of spirometry 
with either computerised expert support or chest physician support Both 
interventions were compared with usual care (spirometry with no additional 
interpretation support) Change of GPs' diagnoses after spirometry testing and 
interpretation served as primary outcome Secondary outcomes were additional 
diagnostic tests, specialist referral rate, and disease management changes 
Differences in change of diagnosis and rates of decision-making indicators before 
and after intervention were expressed as percentages, interventions versus usual 
care, with 95% confidence intervals 
Results Diagnoses changed after intervention in all groups 45 0% (95% CI 39 5 to 
50 6) for software support, 47 8% (95% CI 41 8 to 53 9) for chest physician support 
and 53 3% (95% CI 47 2 to 59 4) for usual care Differences in proportions of 
changed diagnosis were not statistically significant computerised support versus 
usual care (p=0 16), chest physician support versus usual care (p=0 36) There were 
no differences on secondary outcomes 
Conclusion Neither computerised nor chest physician support had a detectable 
impact on GPs' diagnosis of respiratory conditions or management decisions 
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Introduction 
Although major guidelines for chronic obstructive pulmonary disease (COPD) stress 
the central role of spirometry in diagnosing and managing chronic airways disease,12 
spirometry is still underused in primary care, despite increased accessibility34 The 
most common barriers impeding utilisation of spirometry in the GP's practice are the 
absence of properly trained staff,5 the lack of time and practice support to fit 
spirometry into the daily practice routine,6 the absence of a spirometer in the 
practice7 and the GP's lack of confidence in the ability to interpret the test results 8 9 
The latter barrier could theoretically be overcome through expert support 
Expert support for the interpretation of tests of pulmonary function may be made 
available - depending on local circumstances - as a software expert support system10 
or by consultation or feedback from a chest physician In a simulation study we 
recently showed that software support for the interpretation of spirometrie test results 
by GPs did not have demonstrable benefit11 However, GPs welcome support from a 
computer or a chest physician 1 2 1 3 GPs might value support from a chest physician 
more than from software, because chest physicians may act as coaches for their 
local GPs through specific feedback for specific patients, a role computer software 
cannot fulfil In the Netherlands there are already local initiatives between chest 
physicians and GPs with respect to teleconsultation for spirometry test results by 
facsimile However, empirical studies on the effect of this kind of expert support are 
warranted 
The objective of the present study was to assess the impact of two realistic modes of 
expert support (computerised expert support and consultation by a chest physician) 
for the interpretation of spirometrie test results on establishing a diagnosis by GPs, 
and on the GP's decision-making in the management of chronic respiratory disease 
A cluster-randomised design was used to minimise contamination and the unit of 
randomisation and analysis was the general practice 
Methods 
Study design 
We investigated the impact of two modes of spirometry expert support on GPs' 
diagnostic assessment of patients registered with respiratory conditions General 
practices were allocated to one of three groups (ι) software support for interpreting 
spirometry, (n) interpretation of spirometry through teleconsultmg a chest physician, 
or (m) usual care (ι e spirometry without expert software or chest physician support) 
Practices were instructed to perform a spirometrie test for selected patients GPs 
recorded their diagnosis and management before and after spirometry and its 
interpretation (with or without support) using a standardised format Comparison of 
the recordings before and after spirometry provides insight into the influence of the 
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pulmonary function tests with and without expert support on GP's diagnosis and 
patient management For financial, practical and ethical reasons we could not have 
the patients in the study be assessed by a chest physician in order to confirm the 
diagnosis made by the GP's m the participating patients In stead, we conducted a 
separate study parallel to the one reported in this paper that included an expert panel 
assessment of a limited number of well documented respiratory patients from general 
practice 11 
General practices 
181 General practices with a Windows® compatible medical record system from 
three postal code regions in the Eastern part of the Netherlands were invited to 
participate in the study A postal mail was sent via the user groups of two specific 
electronic patient data systems Practices interested in participating in the study were 
requested to contact our department directly 101 Practices responded (56%), 44 
practices participated (Figure 1) 
Patients 
We were specifically interested in those patients in primary care with symptoms such 
as dyspnoea, chronic cough, chronic sputum production, where spirometry is pivotal 
in confirming or excluding airway obstruction 2 1 4 A list of all patients with (apparent) 
chronic respiratory conditions was extracted from the practice patient medical record 
system based on existing diagnostic labels and prescription records for respiratory 
medication Diagnostic labels were the ICPC (International Classification of Primary 
Care (ICPC-1)15 codes R95 for COPD, R96 for asthma and (in practices not using 
the ICPC coding system yet) other codes that are commonly used in Dutch general 
practices to label patients with COPD or asthma We identified repeated (ι e two or 
more) respiratory prescriptions for each patient in the last year using ATC-codes16 
short-acting bronchodilators, long-acting bronchodilators, inhaled steroids, 
anticholinergic agents, and oral mucolytics 
From each practice's selection list we took a random sample (n=40) of all patients 
aged >30 years The sample was weighted to reflect the proportions of patients 
diagnosed with COPD or asthma, and patients who had repeatedly received 
prescriptions for respiratory medication without a formal diagnosis being assigned by 
the GP Patients were excluded from analyses if they were primarily treated by a 
chest physician, had died, or had moved out of the practice In these cases the GP 
included the next patient on the random selection list 
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Figure 1. Flow chart showing study 
participants 
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* from each practice s selection list we look a random sample {n=40) of all patients aged >30 years "* no consultation used for 46 patients 
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/nien/enf/ons 
The intervention pertained to the cluster level (ι e all the GPs in a particular practice) 
General practices were randomly allocated to one of the three study conditions GPs, 
practice nurses, and practice assistants from all participating practices participated in 
a baseline spirometry workshop, which was developed and pre-tested before the 
study 17 Furthermore, all practices were equipped with an electronic spirometer 
(Microloop II® or Microplus®, Micro Medical Ltd, Rochester, UK)10 The expert 
software group was equipped with a software based expert system (SpidaXpert®, 
Micro Medical Ltd, Rochester, UK)1 0 The chest physician supported group and the 
usual care group were equipped with standard spirometry software (SpidaS®, Micro 
Medical Ltd, Rochester, UK)10 
The SpidaXpert® expert software contains a diagnostic algorithm that is based on 
pre- and post bronchodilator FEVi and FEV-i/FVC values and predicted values and 
their lower limits of normal for age, sex, and height In the SpidaXpert® software10 
results are presented using coloured bars that display the pre- and post-
bronchodilator values of FEVi and FEV-i/FVC relative to the 95% confidence limits, 
accompanied by a textual interpretation that provides information on and suggestions 
for additional diagnostic testing and treatment, if appropriate 10 
GPs in the chest physician support group used a printout of the spirometrie test 
results (ι e FEVi, FVC, FEV-i/FVC, MEF50, flow/volume curve) generated by the 
standard spirometry software to communicate with a local chest-physician by 
facsimile Standard forms, which had previously been piloted among 10 GPs and the 
involved chest physicians, were used for the mutual exchange of information 
between GPs and chest physicians GPs in the usual care group did not receive any 
additional support for the interpretation of spirometrie test results 
Pulmonary function tests 
Patients from the practices' random selection lists were offered a spirometry test 
(pre-bronchodilator and post-bronchodilator) either during a regular consultation or 
on separate office hours at the GP's invitation Reasons for patients not to attend the 
practice for the spirometry test were recorded We instructed practices to measure 
forced expiratory volume in one second (FEVi) and forced vital capacity (FVC) until 
three acceptable and reproducible recordings (with a difference <5%) were obtained, 
the highest sum of both values was used to select the best test 
Primary and secondary outcomes 
Change of diagnosis (dichotomised as yes/no) in an individual patient after 
intervention at the GP level served as the primary study outcome GPs' diagnoses 
were inquired using a standardised format which comprised nine pre-pnnted 
diagnostic categories asthma, asthma with persistent obstruction, COPD, restrictive 
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lung disease, diffusive ventilatory defect, heart failure, other respiratory disease, and 
no respiratory disease GPs could record a maximum of three diagnoses per patient 
before as well as after reconsidering the patients' diagnosis after spirometry expert 
intervention (if applicable) In case of one diagnosis before and one diagnosis after 
intervention we defined a change of diagnosis if the content of the diagnosis before 
and after spirometry was not the same In case a GP recorded two or three 
diagnoses before and the same number of diagnoses after the intervention we 
decided on a change of diagnosis if the recorded sets of diagnoses before and after 
intervention were not exactly concordant 
Four predefined secondary outcome measures were assessed to study the potential 
impact of expert software and chest physician support on the GP's decision-making 
process (1) ordering additional diagnostic tests (ι e peak expiratory flow 
measurement, allergy test, diagnostic prednisolone test, chest X-ray, and other 
tests], (2) referral to secondary care (ι e to a chest physician, cardiologist, or other 
specialist), (3) changes in respiratory pharmacotherapy, (4) GP's perception of the 
influence of expert support on their interpretation of spirometry test results (self-
scored on a 5 point scale [1=no influence at all, 5=very strong influence]) 
Sample size 
Calculation of the sample size was based on an estimated relevant 15% change in 
diagnosis between either one of the spirometry expert support groups and the 
unsupported group (ι e , the usual care group) Assuming that 15% of diagnoses in 
the usual care group would change upon reassessment of the diagnosis with the new 
input of the spirometry test result, and assuming a 30% rate of changed diagnoses in 
each of the supported groups, an average of 20 patients per practice from 39 
practices (13 per group) needed to be included in the study (a = 0 05, 1-ß = 0 80, 
mtra-cluster correlation r = 0 07) 
Randomisation of practices 
Restricted computerised randomisation (minimisation) was applied (RA) using three 
stratification factors region (three postal code regions), GP's prior experience with 
spirometry (< 4 or > 4 years), and the proportion of patients receiving repeated 
respiratory prescriptions with a diagnostic label (COPD, asthma) of the total number 
of patients receiving repeated respiratory prescriptions (<50% or > 50%) in a 
practice The researchers and the statistician (RA) were blinded during the analysis 
and writing the results section of this paper Given the nature of the intervention, GPs 
could not be blinded 
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Statistical analysis 
For each study arm change in diagnosis was expressed as percentage with 95% 
confidence intervals (95%CI) We performed multilevel logistic regression analyses 
for dichotomous variables and multilevel regression analyses for continuous 
variables m SAS V8 2 for Windows (SAS Institute Ine, Cary USA 1999-2001) Both 
models were random intercept models, with general practice as a random factor 
All analyses were performed on an intention to treat basis and included all patients 
with a diagnostic assessment by GPs before and after spirometry, regardless of 
actual use of expert support To detect possible effect modification, subgroup 
analyses were performed using Chi-square testing by categorizing patients according 
to a prior diagnosis of asthma or COPD, and patients who had repeatedly received 
prescriptions for respiratory medication without a formal diagnosis 
Results 
Baseline characteristics 
Between February 2004 and May 2006 we enrolled 44 general practices (table 1) 
The software supported group contained slightly more single-handed practices Five 
practices dropped out after randomisation (figure 1) The reasons were too busy 
(n=3), and dissociation of GPs in practices (n=2) Drop-out practices tended to have 
more experience with spirometry, a smaller practice population size and had less 
frequently a practice nurse employed (data not reported) Of the practice staff 85% 
attended the baseline spirometry workshop The mean age of the sampled patients 
was 56 5 years (SD 14 3) There was no statistical difference between the three 
groups for the percentage predicted FEVi or FEVi/FVC values 
The weighted random practice population sample comprised 2098 patients out of a 
total practice population of 92,537 patients (Figure 1) 626 Patients were not eligible 
according to their GP, the two mam reasons being primarily treated by a chest 
physician (75%) and inaccurate reasons for selection (ι e , use of oral corticosteroids 
for rheumatic in stead of respiratory disease) (9%) GPs recorded their diagnosis and 
management before spirometry in 1472 patients Spirometry was not performed in 
517 (35%) of these patients The reasons for not performing spirometry were if 
patients did not respond to the GP's invitation to visit the practice for a spirometry 
test (29%), suffered from severe co morbidity (12%), had died (3%), had left the 
practice (9%), recently had a spirometry test performed (3%), felt they had no 
respiratory problems (5%), and other reasons (39%) GPs recorded their diagnoses 
and patient management decisions again after spirometry in 868 patients A 
diagnosis was missing for 87 patients after spirometry The GPs' reasons for not 
reporting a diagnosis were the standard format was lost (30%), patients had left the 
practice (13%), patients had died (6%), patients were under treatment of a chest 
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physician (8%), GPs could not interpret the spirometry results (13%), and for other 
reasons (30%). There was no difference between the three groups with respect to 
the proportion of patients that had previously had a spirometry test (p=0.21). The 
analysis of all outcomes was based on 868 patients from 39 practices (figure 1 ). 
Table 1 Baseline characteristics of all 44 randomised general practices and 868 
patients 
General practices 
Number of practices 
Type of practice, η (%) 
single handed 
- duo 
- group (> 3 GPs) 
- multidisciplinary health care centre 
Number of patients per GP, range (median) 
Practice nurse present, % yes 
Average experience (years) with spirometry 
of all GPs in practice, range (median) 
Patients 
Number of patients 
Age, mean (SD) 
Gender, % female 
Patients selection from practices' lists 
- with diagnoses of COPD or asthma, η (%) 
- repeated respiratory 
prescription without formal diagnosis, η (%) 
Spirometry results* 
Number of patients 
FEV,, mean (SD) 
FEV, % predicted 
FEV^FVC %, mean (SD) 
Usual Care 
15 
5(33) 
5(33) 
4(27) 
1(7) 
640-2800(1750) 
33 
1-10(4.0) 
272 
55(13.9) 
62.5 
164(60) 
108(40) 
170 
2.57 (0.89) 
88.26(21.09) 
71.71 (10.89) 
Software 
support 
15 
10(67) 
5(33) 
-
-
712-3400(1600) 
47 
0-14(3.0) 
320 
59(14.3) 
58.1 
178(56) 
142 (44) 
239 
2.34 (0.90) 
83 12 (22.59) 
72.02(12.18) 
Chest physician 
support 
14 
5(36) 
4(29) 
4(29) 
1(6) 
783-2880(1545) 
29 
0-11 (4 5) 
276 
55(14 4) 
54.7 
189 (69) 
87(31) 
174 
2.66 (0.84) 
87.80(18.69) 
75 73 (9.45) 
* Electronic data available for 33 out of 39 practices, we could not extract the database of the 
spirometry software in 6 general practices due to changes in hardware during the study that led to lack 
of compatibility of USB ports and disk drives 
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Primary outcome change of diagnoses in the analysed patient population 
Before spirometry, GPs recorded a total of 954 diagnoses (1 10 diagnosis per 
patient) In 91% of the patients GPs recorded one diagnosis, in the remaining 9% 
more than one diagnosis The GPs in the software supported group less frequently 
reported more than one diagnosis compared to the GPs in the other groups 
(p=0 006) Sorted by frequency the recorded diagnoses were asthma (n=450), 
COPD (n=270), no respiratory disease (n=102), asthma with persistent obstruction 
(n=52) and other diagnoses (n=80) 
After spirometry GPs recorded a total of 985 diagnoses (113 diagnoses per patient) 
In 87% of the patients GPs recorded one diagnoses, in the remaining 13% two or 
more diagnoses These diagnoses were asthma (n=416), COPD (n=266), no 
respiratory disease (n=152), asthma with persistent obstruction (n=66) and other 
diagnoses (n=85) 
In all three groups of analysed patients the diagnoses changed considerably after 
spirometry 45 0% (95% CI 39 5 to 50 6) with software support, 47 8% (95% CI 41 8 
to 53 9) with chest physician support and 53 3% (95% CI 47 2 to 59 4) with usual 
care The differences were not statistically significant software support versus usual 
care (p=0 16), chest physician support versus usual care (p=0 36) The mtra-cluster 
correlation was 0 065 
Table 2 provides detailed insight into change of a COPD diagnosis after spirometry 
for the subgroup of patients aged > 40 years COPD diagnoses changed in patients 
as follows 20 1% (95% CI 15 7 to 25 2) with software support, 23 5% (95% CI 18 2 
to 29 5) with chest physician support and 27 1% (95% CI 21 4 to 33 4) with usual 
care These differences were not statistically significant software support versus 
usual care (p=0 09), chest physician support versus usual care (p=0 42) 
Table 2 Differences in the proportion of changed COPD diagnoses after spirometry 
as indicated by the GP in patients aged > 40 years 
Usual care 
(n = 225) 
Software support 
(n=293) 
Chest physician support 
(n=230) 
Posterior diagnosis Posterior diagnosis Posterior diagnosis 
Prior diagnosis 
COPD 
Yes, % 
No, % 
COPD 
Yes,% No,% 
25 3 14 6 
12 4 47 5 
COPD 
Yes,% No,% 
22 5 116 
8 5 57 3 
COPD 
Yes,% No,% 
22 2 9 6 
13 9 54 3 
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Figure 2 depicts the direction of change of a diagnosis from before to after 
spirometry. The additional value of spirometry testing appeared to be substantial in 
all three groups. Generally, most changes were observed among GPs who did not 
receive expert support. A prior diagnosis of COPD (Fig 2a) changed in -35% into 
another diagnosis (mostly asthma); this shift in diagnoses was not statistically 
significant different between the groups: software support versus usual care (p=0.13), 
chest physician support versus usual care (p=0.09). 
A prior diagnosis of asthma (Fig 2b) changed in -30% of cases; this shift was 
significantly different between groups: software support versus usual care (p=0.01), 
chest physician support versus usual care (p<0.001). 
Finally, the diagnosis "no respiratory disease" (Fig 2c) changed in -50% of cases 
(mostly into asthma or COPD); this shift in diagnoses was not significantly different 
between the groups; software support versus usual care (p=0.77), chest physician 
support versus usual care (p=0.24). 
Table 3 Secondary outcomes: Impact of the spirometry interventions on three 
indicators of GPs' decision-making process.* 
Indicators 
(1 ) Additional diagnostic tests#, % 
(2) Specialist referral rate", % 
(3) Changes in respiratory 
pharmacotherapy$,% yes 
Stop medication,% 
- short acting bronchodilators 
- long acting bronchodilators 
- inhaled corticosteroids 
Start medication,% 
- short acting bronchodilators 
- long acting bronchodilators 
- inhaled corticosteroids 
Usual care 
(N=272) 
12.5 
52 
39.0 
47.4 
46.2 
53.5 
10.2 
4.5 
11.7 
Software 
support 
(N=320) 
18 1 
5.7 
38.9 
53 2 
43.5 
36 7 
13.5 
7.1 
8.3 
Ρ 
0 21 
0.82 
0.97 
0.68 
0 88 
0.11 
0.40 
0 37 
0.37 
Chest physician 
support 
(N=276) 
8.7 
7.6 
32 7 
42 9 
57.1 
38.8 
79 
1.9 
15.9 
Ρ 
0.32 
0.23 
0.25 
0 58 
0.57 
0 26 
0 55 
0.34 
0.42 
* Ρ values apply to testing software support versus usual care and chest physician support versus 
usual care 
# Additional diagnostic tests included peak flow measurement, allergy test, diagnostic prednisolone 
test, chest X-ray, histamine provocation test and electrocardiography. 
** Referrals included: chest physician, cardiologist, internist and ENT-surgeon 
$ We report about 146 patients (usual care), 247 patients (software support), and 16Θ patients (chest 
physician support) Due to technical problems with software data for medication prescriptions were 
missing for 46.3% of the patients in usual care group, for 22 8% in software support group, and 39% in 
chest physician support group 
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Figure 2 Diagnosis after spirometry in patients with a diagnosis before spirometry of 
COPD (a), asthma (b) and no respiratory disease (c). 
Fig 2a. Diagnosis before spirometry: COPD (n=270) 
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Secondary outcomes indicators of GP's decision-making 
There were no differences between software support or physician support compared 
with usual care for the additional diagnostic tests rate, the referral rate, or for 
changes in respiratory pharmacology (table 3) Data on prescriptions were only 
available for 65% of the practices, the missing patients were more frequently female 
and slightly younger (data not reported) 
GP's self-scored perception of the influence of expert support for the interpretation of 
the spirometry test on assigning a diagnosis was (mean (SD)) 2 4(12) with software 
support and 2 2 (1 7) with chest physician support, the latter low figure may have 
been affected by the fact that a chest physician was never consulted in 16% of 
cases 
Subgroup analyses 
Based on the initial selection lists from the practices that we used to identify patients 
for this study, we distinguished two categories of participants patients who already 
had a prior diagnosis of asthma or COPD, and patients selected because they had 
received repeated respiratory prescriptions without a formal diagnosis being assigned 
by their GP (see Table 1) We found a difference in change of diagnosis after 
intervention changes were more frequent in patients without a formal prior diagnosis 
(56 4%) than in patients with a prior diagnosis of COPD or asthma (43 6%) 
(p<0 001) In the patients without a formal diagnosis this change differed statistically 
significant between the software support and the usual care group (p=0 05), but not 
between the chest physician support and the usual care group (p=0 46) 
Discussion 
Mam findings 
Spirometry was important for GPs' diagnosis but no added value on their decision-
making could be found for software expert support or chest physician support in 
establishing a final diagnosis in patients with chronic respiratory symptoms In over 
40% of cases spirometry led to modifying the diagnosis Not surprisingly, diagnoses 
changed more often in patients in whom a formal diagnosis had not been made prior 
to spirometry but this was the case in all three study groups Overall, support for the 
interpretation of spirometry tests did not seem to influence GP's decision-making 
process 
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Strengths of the study 
This is the first study that assesses the impact of two current modes of expert support 
for interpreting spirometry in a randomised design in primary care We offered 
standardised training and supplied practices with the same equipment, thus creating 
a uniform point of departure in the three study groups To avoid bias analyses were 
performed blinded by both the investigators and the statistician (RA) As the 
participating general practices were not specifically selected the external validity of 
the results is good despite the fact that the study was organised in the Eastern part 
of the country, we have no reasons to assume that the results are not applicable to 
other parts of the country where GPs perform spirometry in their own practice We 
selected patients with a prior diagnosis of asthma or COPD for revision of the current 
diagnosis, and patients who had repeatedly received prescriptions for respiratory 
medication without a formal diagnosis for assessing a new diagnosis For both 
categories of patients spirometry seems to have additional value 
Possible limitations 
Our study has some limitations We could only look at changes in GP's diagnoses, 
rather than changes in the correctness of their diagnoses Although the latter option 
would have been more informative, financial, practical and ethical barriers were 
perceived in sending a patient to an expert (ι e a chest physician) to confirm and re-
diagnose the patient in a short time 
Despite randomisation, we found some between-group differences in patient 
characteristics that might have influenced the results of this study In the software 
support group the absolute and relative number of patients that had been evaluated 
was larger than in the other groups Moreover, the mean FEVi and FEVi% predicted 
were lower Contrary, in the chest physician supported group the mean FEVi/FVC 
ratio was higher and the standard deviation smaller, thus this patient population was 
more homogeneous with less severe pulmonary obstruction 
Finally, we did not ask GPs if our method of the patient selection matched their 
opinion of clinical relevancy Therefore we cannot explain why many patients without 
a formal diagnosis were being assigned with a new diagnosis Possibly, a GP has no 
detailed insight into the prescriptions in daily practice Alternatively, a GP might 
regard patients with recurrent cough as having (seasonal) intermittent infections, 
without feeling a need for additional diagnostic investigations 
Relation with other studies 
The observed change of diagnosis after spirometry and the effects on 
pharmacological management are in line with the results from other studies 1 8 1 9 
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However, these studies reported on a change of diagnosis (20-70%) after adding 
information (spirometry) required to demonstrate obstruction which was, for whatever 
reason, not available before 1 8 1 9 It is quite surprising that in our setting both kinds of 
expert support did not seem to influence the GPs' diagnostic approach and decision­
making Difficulties in differentiating between COPD and asthma appears to be 
common in primary care 20 Changing a diagnosis does have consequences for 
clinical practice a new diagnosis of asthma was commonly made in patients with a 
former diagnosis of COPD or subjects judged to have no respiratory disease In 
these cases prescriptions for respiratory medication (ι e, starting inhaled 
corticosteroid treatment) will need to be initiated 
From a recent in-depth evaluation of the same spirometry expert system that was 
used in this study we know that expert support does not seem influence GP's 
decision-making in a simulated setting 11 From that study we also know that GP's 
diagnostic correctness was about 67% Another descriptive study found that a GP is 
able to predict a diagnosis of COPD or asthma correctly in up to 75% of cases based 
on simple criteria 21 Both studies suggest that the added value of expert support on 
the correctness of a diagnosis is low Although we anticipated that support from a 
chest physician would have influenced GPs more often than the software support, 
GP's perception of this kind of support on their diagnostic choices or decision-making 
was similar 
Software support has been a hot topic in the literature on medical informatics in the 
past decade Recently, an updated systematic review showed that effects of 
computerised decision support on doctor's performance in diagnostic evaluations 
were low2 2 For respiratory conditions, only the study of Kuilboer ei al reported a 
positive effect of a guideline-based critiquing system on GP's monitoring (not 
diagnosing) of asthma and COPD 23 Contrary to a critiquing system that provides 
explanations based on a GP's formulated decision, the spirometry expert system we 
used in our study does not provide feedback to a GP's own formulated decision, it 
automatically generates comments based exclusively on spirometrie data 
Theoretically, the correspondence model with the chest physician that we used 
resembles a critiquing system GPs had to formulate their working diagnosis and 
treatment in order to get feedback on their facsimile However, we did not find 
statistically relevant influence on GP's decision-making Neither the current study in 
clinical practice, nor the simulation study performed earlier11 can be added to this 
short list of effective diagnostic support systems 
59 
Unanswered questions and future research 
Despite the availability of guidelines, diagnostic confusion between asthma and 
COPD is common 20 In about 40% of cases spirometry led to modifying the diagnosis 
and management, regardless of the use of expert support However, we do not know 
if the changes in our study have direct implications on patient outcome 
There is another dilemma On the one hand GPs express a need for expert support13 
as interpreting spirometry seems difficult,89 on the other hand trained GPs have 
shown to diagnose respiratory conditions accurately 1124 From the current study we 
know that GP's perception of this expert support had no influence on their diagnostic 
choices and decision-making Therefore, we should look for other GP-related factors 
that make them uncertain to interpret the tests Qualitative studies are necessary to 
address this point25 
Finally, the need for high quality test results in primary care remains because only 
tests of sufficient quality are useful for clinical use Although m research settings 
trained practice staff have demonstrated that they can perform spirometry of 
sufficient quality,17 the optimal model for performing spirometry among untrained 
practice staff is unclear The current models with software or chest physician support 
do not seem to be adequate However, several COPD support services, in which 
chest physicians work together with specialised lung nurses and a regional primary 
care laboratory, may be more appropriate in primary care1926 Whether these 
services are superior in terms of correctness of a diagnosis to withm-practice testing 
would require further research 
In conclusion, spirometry was important for GPs' diagnosis but their decision-making 
was neither affected by software support nor by chest physician support, compared 
to usual care for chronic respiratory disease 
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7 
General discussion and conclusions 
This thesis has given new insight into the effect of spirometry expert support in 
general practice. At the start of this thesis (2002), logistic problems of organisation of 
spirometry in general practice and infrequent utilisation were relevant barriers to daily 
application. We introduced and evaluated two modes of spirometry expert support to 
facilitate GPs' diagnostic achievements in this challenge. The main findings from this 
thesis are. 
• GPs used spirometry mostly to evaluate treatment with inhaled steroids (-60%). 
GP-related factors associated with spirometry utilisation were' GPs' job 
satisfaction, GPs' general interest in research, and prior participation in spirometry 
training. Practice-related factors associated with spirometry utilisation were: 
presence of a practice nurse, delegation of medical tasks to practice assistants, 
use of spirometry in different rooms, and use of protocols in practice. Especially 
practice-related factors are concrete to improve spirometry utilisation (e.g. 
presence of a practice nurse, more delegation of medical tasks to the practice 
assistant). 
• About 70% of the GPs expressed the need for ongoing support for the spirometry 
test interpretation. The preferred mode of support was either by a chest physician 
(51%) or by a computerised expert support system (46%). Recent spirometry 
training seemed to partially dimmish this need for expert support. 
• Guidelines stress the central role of spirometry in diagnosing and managing 
COPD in primary care, but this does not guarantee that GPs will use spirometry 
consistently due to several barriers: absence of an own spirometer, lack of trained 
staff, and lack of GP's confidence to interpret test results. Coordinated efforts by 
health policy makers and the medical profession will be needed to provide the 
right equipment, training for staff who use it, and continuing quality assurance and 
support for test interpretation. 
• In a simulated setting computerised spirometry expert support for the 
interpretation of spirometry tests by GPs had no detectable benefit over sham 
information on GPs' diagnostic achievements of chronic respiratory disease. GPs 
were able to diagnose 65% of the cases correctly. Overall, input of expert support 
did not seem to influence GPs' decision-making process. 
• In a clinical setting neither software expert support nor chest physician support 
represented detectable added value over no support in establishing a final 
diagnosis in patients with chronic respiratory symptoms. In over 40% of cases 
spirometry led to modification of the pre-existing diagnosis. Diagnoses changed 
more often in patients in whom a formal diagnosis had not been made prior to 
spirometry. Finally, expert support did not influence the GPs' decision-making 
process. 
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The results of this thesis showed that GPs were quite able to interpret spirometry 
tests correctly and expert support had no apparent additional value In the mean time 
(2002-2007), several external factors have influenced the increase of the volume of 
spirometry tests in general practice in our country, the introduction of the practice 
nurse on nationwide scale, the introduction of a financial incentive for GPs for 
spirometry tests, increased availability of spirometers, and a new guideline for COPD 
that gives spirometry a central role in diagnosing and staging this disease The 
increasing volume of spirometry tests performed stresses the importance of 
spirometry quality assurance in general practice Furthermore, which training 
methods or feedback are suitable to optimise and monitor spirometry test 
performance and interpretation in the near future9 In the subsequent paragraphs the 
mam findings from the studies reported in this thesis are discussed, and put in 
perspective of practical implications and recommendations for future research 
Influence of spirometry on diagnosis and management 
Recent studies showed the important influence of spirometry on GPs' diagnosis and 
management1 5 Results from the HASPIR study from our own research department 
show that in a simulation setting spirometry reduces GPs' diagnostic uncertainty, but 
increases the use of additional diagnostics and referrals3 In a practice setting 
spirometry showed impact on pharmacological and nonpharmacological 
management2 The most striking finding m chapter 6 was how much the results of 
spirometry affected a final diagnosis In about 40% of cases the results led to 
modification of a pre-existing diagnosis This is not surprising for a respiratory 
condition where the diagnosis often hinges on the presence or absence of airway 
obstruction (such as in COPD), and on the reversibility of airway obstruction After all, 
no GP would ever think of treating hypertension without having established high 
blood pressure, and similarly treating patients with chronic respiratory symptoms 
without assessing their pulmonary function should become a thing of the past The 
results of this study (chapter 6) underscore again the importance of office spirometry 
for the treatment of patients with chronic respiratory symptoms However, the study in 
chapter 6 was not designed to specially investigate the additional value of spirometry 
Upcoming studies should focus on this additional value of spirometry on top of 
history-taking and clinical examination in subjects who consult their GP with signs 
and symptoms that may point to an underlying obstructive airway disease 67 
Computerised expert support and chest physician support 
The results of the explorative study in chapter 3 demonstrate that 70% of the GPs 
welcomed continuous support for the interpretation of their test results GPs preferred 
a local chest physician or pulmonary function laboratories or a computerised expert 
support system Another option would be support from a GP with a special interest in 
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respiratory disease in the same practice or in another practice nearby If such a GP 
is not available or this kind of task differentiation between GPs in a general practice 
group is not possible a chest physician can act as coach for local GPs in two ways 
through patient oriented support (specific feedback for specific patients) or through 
practice oriented support (as teachers in postgraduate training programmes) (chapter 
4) Results of the studies presented in chapter 5 add to knowledge that computerised 
spirometry expert support had no detectable benefit over sham information on GPs' 
diagnostic achievements and decision-making process when diagnosing chronic 
respiratory disease Contrary to our prior expectations, the results of the study 
presented in chapter 6 showed that neither chest physician support, nor 
computerised expert support had detectable impact on GPs' diagnosis and 
subsequent management of respiratory diseases Although we expected that support 
from a chest physician would have influenced GPs more than the software support, 
GPs' perception of this kind of support on their diagnostic arsenal was similar 
Expert support has been a hot topic in the literature on medical informatics the past 
decade Recently, a third update of a systematic review shows that effects of 
computerised decision support on the doctor's performance in diagnostic evaluations 
is low9 Most studies in this review focussed on effective strategies of computerised 
support systems related to disease management systems, drug-dosing or prescribing 
systems or reminder systems The minority focussed on diagnostic systems For 
respiratory conditions, only the study of Kuilboer ef al10 reported a positive effect of a 
guideline-based critiquing system on GP's monitoring of asthma and COPD Contrary 
to a critiquing system that provides explanations based on a GP's formulated 
decision, the expert system used in our study (Spirxpert or SpidaXpert®) does not 
provide feedback to a GP's own formulated decision, it automatically generates 
Preformatted comments based exclusively on spirometrie data Theoretically, the 
correspondence model with the chest physician that we used resembles a critiquing 
system GPs had to formulate their working diagnosis and treatment in order to get 
critique on their facsimile However, we did not find statistically relevant influence on 
GP's decision-making 
Successful examples of other diagnostic expert systems used in collaboration 
between primary and secondary care are scarce For dermatologie conditions, 
teledermatology consultations (ι e similar with the teleconsultation of the chest 
physician in our study) have shown to be effective to reduce the number of referrals 
by 25- 50% 1 1 1 2 This is probably due to the fact that dermatologie conditions ask for a 
visual inspection rather than a complex physiologic evaluation and interpretation in 
pulmonary conditions 
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General role of expert support in general practice 
There is a dilemma On the one hand decision support systems are promoted as tool 
to improve primary care for patients with chronic illness 13 On the other hand there is 
a lack of effective diagnostic expert support systems that have been tested with 
success in general practice populations This could be due to some features of the 
expert systems, or due to some features of the users of these systems, or both A 
recent rigorous review of trials to identify features critical to success identified four 
predictors of effective decision support (1) systems that enhance practice generate 
decision support automatically as part of the normal clinical workflow and at (2) the 
time and place of decision making, (3) they use computers to deliver support, (4) and 
they offer specific recommendations rather than mere assessments 1 4 1 5 Although the 
expert support system we used meets the criteria of a good system - involvement of 
authors by development, integrated in computer, displaying specific 
recommendations at the right place and time - it was not actually tested m the target 
group (ι e GPs) before the study Therefore, it may not optimally fit into the decision­
making process of GPs The information presented by the spirometry expert system 
to the GP possibly lacked explanation of what the output exactly means These are 
known barriers to the adoption of expert support in primary care 16 Other barriers that 
influence the adoption of clinical decision systems in general practice are time 
pressure in primary care, barriers arising from infrequent use, GP concerns about 
patient reaction if they use a support system, limited skills and confidence in 
information technology, difficulties m data entry, and problems related to the given 
advice1 6 1 7 These factors may possible have influenced the results of our studies 
reported m chapter 5 and 6 
Introduction of a practice nurse 
The new discipline of practice nursing has been introduced on a nationwide scale in 
Dutch general practices m the last five years These nurses are trained to do 
supporting tasks in chronic diseases, especially diabetes and chronic respiratory 
conditions (COPD and asthma) They work under direct supervision of a GP and 
generally follow protocols to provide non-acute medical care (for instance, assisting 
smoking cessation) and patient education It is estimated that approximately 65% of 
all general practices m our country have a practice nurse employed to support the 
care for their patients with COPD and asthma (Schellekens, August 2007, personal 
communication) In chapter 2 we observed a positive relation between spirometry 
utilisation m a practice and the presence of a practice nurse Although a practice 
nurse can probably take over specific tasks (ι e spirometry test performance) from a 
GP without reducing the quality of care, the exact effects of the involvement of a 
practice nurse is not known From a Dutch study on the effects of a practice nurse on 
care given to patients with asthma or COPD we learned that patient satisfaction 
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improved with the care provided by these nurses, but we also learned that this does 
not reduce the GP's workload 18 The results of a systematic review on this topic 
showed that there is overall little robust evidence to support nurse management of 
chronic disease services for COPD 19 However, further research is necessary to 
determine the exact value of the practice nurse on specific elements of the care 
given to patients with COPD or asthma (e g spirometry performance, and test 
interpretation) 
Spirometry: availability, utilisation, and incentives 
There are global differences between developed countries with respect to the 
availability of office spirometers In Italy, the use of office spirometers is low and GPs 
do not have serious alternatives of open-access to spirometry facilities or pulmonary 
function laboratory20 Contrary, in other countries spirometers are available in the 
majority of the general practices (65% in Australia,21 66% in the United States,22 and 
91% in Spam23) In the Netherlands, up to 65% of the general practices has an own 
office spirometer (Schellekens, August 2007, personal communication) GPs in our 
country buy spirometers themselves or pharmaceutical industries offer or let GPs 
handheld spirometers, for screening purposes 
Since 2003, literature has risen about the (under) utilisation of spirometry in general 
practice2025 Despite increased accessibility and despite the fact that national 
guidelines in most countries give hand-out to GPs when to use spirometry, there is 
apparently still underuse of spirometry in most countries2328 This underuse has 
something to do with GPs' believe that spirometry is not necessary to diagnose 
COPD 20 A clear consequence of this is given by a Belgium survey that demonstrated 
that more than half of the GPs assessed a diagnosis of COPD without performing 
spirometry 24 Other factors that explain underuse of spirometry in the GP's practice 
are the absence of properly trained staff,29 the lack of time and practice support to fit 
spirometry into the daily practice routine (chapter 3), the absence of a spirometer in 
the practice,25 inadequate reimbursement of spirometry tests,30 and GP's lack of 
confidence m the ability to interpret the test results 31 
The actual use of spirometry in our country has increased the last years Based on 
information from an insurance company in the South-West part of our country, we 
know that in 2006 200 000 spirometry tests were performed in general practices 
(Schellekens, August 2007, personal communication) A further 25 000 tests were 
performed in regional primary care diagnostic services and 10 000 tests were 
performed in hospital based pulmonary function laboratories with open access for 
general practice patients The number of tests performed in general practice has 
almost doubled the last three years The higher financial incentives for GPs to 
perform spirometry (since 2006) could partly explain this increase In conclusion, in 
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our country the availability of spirometers and the actual use of spirometry tests have 
risen the last years. 
New national COPD guideline 
The recent guideline for diagnosing and managing of COPD32 stressed the important 
role of spirometry in diagnosing COPD in Dutch general practice. Although symptoms 
and clinical signs enable GPs to predict a diagnosis of COPD or asthma correctly in 
up to 75% of cases,33 spirometry can play an additional role in diagnosing and 
management of respiratory diseases in several ways;3435 by assessing a new 
diagnosis of COPD, by accurate severity staging in patients who have previously 
been diagnosed, by differentiating between COPD and asthma, by monitoring a 
treatment of inhaled steroids, or by screening smoking adults for airflow obstruction. 
The results in chapter 2 show that GPs in the Netherlands did not use spirometry for 
all indications from national guidelines consistently; GPs used spirometry mostly for 
diagnostic and monitoring purposes and rarely for screening purposes. However, 
there is a tendency today to promote screening among smoking patients for the 
presence of COPD, despite the fact that the value of screening for COPD is 
unknown.36 A recent European study demonstrated that 8.0% of patients between 
20-44 years of age are at risk for COPD (Gold stage 0) in the Netherlands.37 
However, smoking cessation is the only effective treatment for patients with COPD38 
and the results of smoking cessation programs are disappointing. Therefore GPs 
should not focus on these asymptomatic patients. GPs should focus on symptomatic 
current or former smoking patients in their practice.39 These patients deserve a 
systematic pulmonary evaluation, including full spirometry testing. Starting such a 
diagnostic evaluation in stead of just prescribing antibiotics is enough challenge for 
GPs. 
Spirometry quality assurance 
Given the increased volume of spirometry tests in general practice, there is a need 
for high quality test results in primary care because only tests of sufficient quality are 
useful for clinical use. The exact model how to organise spirometry performance and 
interpretation in general practice is unknown and depends on local circumstances.40 
Although in research settings trained practice staff have demonstrated that they can 
perform this spirometry of sufficient quality41 little is known about the quality of 
spirometry tests outside a research setting. 
We recently found that the quality of spirometrie tests performed in the general 
practices that were not involved in spirometry research activities was adequate; the 
reproducibility of FEVi and FVC was < 5% and < 200 ml for 85% and 82% of the 
1282 spirometry tests that were available for review.42 The duration of the forced 
expiration was concrete to improve. One option to increase test performance is 
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simply by an intervention like a periodic outreach visit by lung function technicians in 
primary care.43 Another option is the use of continuous training of test performance 
by means of a new CD (Spirometry Fundamentals©).44 
If GPs perform spirometry in the own practice, they should own a diagnostic 
spirometer that provides the flow-volume as well as the volume-time curve to be able 
to assess acceptable test results adequately.45 GPs should regard implementation of 
quality checks for their equipment as well as for the test procedure itself as an 
inevitable part of their work if they want to take the use of spirometry in the 
management of their patients seriously.46 The new guidelines from the ATS/ERS45 
provide clear instructions for the performance and interpretation of spirometry. A 
simplified instruction for the performance and a structured interpretation of spirometry 
tests is now already available for practice nurses, practice assistants47 and GPs.48 
However, this ATS/ERS guideline45 needs to be translated to general practice to be 
implemented successfully. In the Netherlands the primary care group for COPD and 
asthma (www.cahaq.nl) will soon start with this challenge. In conclusion, spirometry 
outside a research setting seems possible with adequate equipment and 
maintenance of the training level of professionals.49 
Spirometry training methods 
It is clear that GPs experience barriers to the consistent use of spirometry.50 Good 
studies why GPs sustain or refrain from spirometry even if they have an own 
spirometer available are scarce. Qualitative research methods, such as in-depth 
interviews and focus-group studies are indicated to explore barriers to spirometry 
utilisation.51 Although two studies have been performed on this topic52,53 the results of 
one intervention study has not been published52 and the results of the other small 
study should be interpreted with caution because of the poor study design.53 The 
main reasons in this latter study why GPs perceive barriers to spirometry were GPs' 
reluctance to make a formal diagnosis with use of spirometry, and GPs' low 
confidence in ability to interpret the test results. Two recent studies showed again 
that GPs have difficulties with interpretation of spirometry tests in daily practice.31,54 
Therefore, several efforts to increase GP's knowledge about or experience with 
spirometry interpretation have been investigated. Examples of generic methods to 
achieve this goal are by teaching spirometry through the internet,55 by educational 
articles,56 guidelines45 or fact sheets,57 by teaching spirometry earlier in medical 
schools58, by teaching spirometry in the vocational training for GPs, or by initiatives to 
standardise spirometry postgraduate training 59 None of these before mentioned 
generic methods to increase GPs' knowledge about spirometry interpretation have 
been studied thoroughly on its effect in daily practice. 
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Some methodological considerations 
From a methodological point of view there are some remarks with respect to the 
presented studies m this thesis 
Firstly, the information about the variation in utilisation (chapter 2) and the need for 
expert support (chapter 3) was based on a rather selected group of 144 GPs who 
participated m a spirometry training program 41 Although not presented elsewhere, 
the information on the need of expert support among GPs was derived from only 144 
out of approximately 8200 GPs in our country We do not know if their opinions fully 
reflect the situation in Dutch general practice 
In addition, the case evaluation study (chapter 5) was artificial in that sense that the 
prevalence of disease did not reflect the true population prevalence For instance, 
restriction is a rather rare disease It is difficult to know exactly how many different 
cases (e g obstruction, restriction, and insufficient test performance) could be used 
to reflect actual prevalence's of the disease patterns within the constitution of the 
case In reflection, we could have used in the mix of the case descriptions of the 
simulation study m chapter 5, more COPD cases (GOLD stage 1 or 2) in stead of 
GOLD stage 3 In daily general practice, GPs are most confronted with COPD 
patients classified as GOLD stage 1 (27%) and 2 (55%)60 
Another methodological problem has been unanswered with respect to the case 
study Presently, we randomised the GP as unit of analysis Another option would 
have been to randomise each case per GP Which one preferred is unknown 
Furthermore, the actual use of the expert system (chapter 6) should have been 
monitored preferably by means of a log system that could have given us insight into 
the use of the database In the present design, we are not completely sure that GPs 
have seen the interpretative results themselves Practice nurses, who perform often 
spirometry, could have interpreted the results for the GPs when we asked them to 
return the standardised formats after spirometry test had been performed We have 
tried to arrange for a "user log" in the expert system, but for technical reasons this 
was mfeasible 
Subsequently, we did not ask GPs if our method of the used patient selection 
matched their opinion of clinical relevancy (chapter 6) Therefore we cannot explain 
why many patients without a formal diagnosis were assigned with a new diagnosis 
Possibly, a GP has no detailed insight into the prescriptions m daily practice 
Alternatively, a GP might regard patients with recurrent cough as having (seasonal) 
intermittent infections, without feeling a need for additional diagnostic investigations 
Furthermore, we did not analyse specifically the databases of the spirometry results 
from all the practices We asked on a standard form GPs' interpretation of the test 
results, without checking the raw spirometrie data for each patient This would have 
been given more information about the interpretation of the GPs given the raw data 
It would also give insight into the number of tests performed before and after 
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bronchodilators and GPs' selection of the best tests. This is definitely worth further 
study. 
Finally, due to changes in hardware that led to lack of USB ports and disk drives we 
could not copy the database of the spirometry software in 25% of the practices and 
we could not use data about prescription in 35% of the practices. 
Conclusions and recommendations for daily practice and future research 
In conclusion, in general practice diagnostic spirometry is an essential tool in patients 
with recurrent symptoms such as dyspnoea, chronic cough, and chronic sputum 
production. Due to spirometry a pre-existing diagnosis will change in 40% of the 
patients. GPs are quite able to diagnose common respiratory disease patterns. Given 
this high prior probability of correct interpretations of spirometry test results (up to 
70%), the role for expert support to change diagnosis and management is small. 
Neither support by expert software nor by a chest physician had influence on the 
diagnostic achievements of GPs in patients with respiratory conditions. Expert 
support did not influence GP's referrals or additional diagnostic tests. There is a 
discrepancy between the objective diagnostic achievements of GPs and their own 
perception of the capability to interpret the spirometry results, probably due to 
infrequent test interpretations. Further qualitative studies are necessary to address 
this point. Given the low frequency of spirometry use in daily practice, centring of 
interpretation expertise seems necessary. The optimal model to realise this in 
general practice is a main challenge for further research. 
Based on this thesis the following recommendations can be given: 
• We should look further for other GP-related factors that make them uncertain to 
interpret the tests. On the one hand GPs experience barriers to spirometry test 
results interpretation (chapter 3). On the other hand GPs are quite capable to 
assess a respiratory diagnosis adequately3,29 (chapter 5). From the results of 
chapter 6 we know that GP's perception of expert support had no influence on 
their diagnostic choices and decision-making. A qualitative study is necessary and 
suitable to address this point by organising a focus group study with users of an 
expert system. This focus group study should also identify GP's preferences with 
respect to the specific features of expert support. 
• The current models with expert software or chest physician support are not 
adequate enough. Several new COPD support services, in which chest 
physicians work together with specialised (lung) nurses and a regional primary 
care laboratory, may be more appropriate in primary care.261 The question arises 
where should spirometry testing being performed in terms of correctness of a 
74 
diagnosis, adequacy of test results, or patient fnendlessness general practice, 
the regional primary care laboratory or in the hospital9 Given the numbers of 
spirometry tests being performed in 2006 the preferred logistic way is certainly 
somewhere in a primary care setting Chest physicians can give valid 
interpretations of the lung function of patients in general practice by means of 
written information where GPs can trust on 62 From another part of medicine 
(dermatology) we know also that patients prefer services from GPs with a special 
interest in dermatology above hospital outpatient care 63 For spirometry testing 
presently four models are realistic in the Netherlands (1 ) spirometry performed by 
a practice nurse and interpreted by a GP, (2) spirometry performed by a practice 
nurse and interpreted in general practice by a GP with special interest in 
respiratory disease in the same practice or nearby, (3) spirometry performed by a 
nurse in a regional primary care laboratory and interpreted by either a chest 
physician or a GP with a special interest m respiratory disease, (4) spirometry 
performed at the hospital pulmonary function laboratory by lung function 
assistants and interpreted by a chest physician Further randomised studies are 
necessary to assess the optimal spirometry setting 
• Although not mentioned in other studies the absence of a well integrated 
spirometry software system in the electronic medical record system is probably a 
relevant barrier in Dutch general practice Presently, there are more than seven 
different electronic medical record systems and more than 25 different 
spirometers on the market Only a few brands of spirometer have software that 
can be integrated with only three electronic medical record systems Integration of 
the results of spirometry tests in the electronic medical record system (including 
excellent documentation of the test results) in stead of a stand-alone use of the 
spirometry software on a separate computer will definitely facilitate GPs to apply 
spirometry in daily practice routine more often We encourage manufactures of 
spirometers and software to develop adequate new interfaces with Dutch 
electronic medical record systems Meanwhile, GPs can visit (soon) the website 
of the Dutch College of General Practitioners (www nhg org) to get insight into the 
features and restrictions of the available diagnostic spirometers and accompanied 
software that are currently available m the Netherlands 
• It is necessary to adjust the computerised spirometry expert support system in 
order to take GPs by the hand and lead them to the diagnostic assessment, an 
expert system should use a stepwise approach and quickly offer concise textual 
and visual summaries of most important test results In this stepwise approach a 
GP should work through a couple of sentences in one screenshot that contains 
the individual items of the interpretation of spirometry tests results acceptability of 
75 
test results, reproducibility of the test results, flow-volume and volume-time curve, 
presence of obstruction, severity of obstruction, reversibility of obstruction 
followed by the graphical and textual interpretation by the expert software. A new 
study would be necessary to assess the feasibility of this new expert system 
among potential users. 
As the effect of the current spirometry expert system was neither associated with 
GPs' professional experience nor with GPs' weekly number of spirometry tests 
interpretations, we can not specially recommend the current expert system to GPs 
in daily practice. 
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Summary 
Chapter 1 
In this chapter the rationale for this thesis is explained Chronic obstructive 
pulmonary disease (COPD) and asthma are prevalent chronic respiratory conditions 
that will continue to cause increased disability in the world's population in future 
years COPD and asthma are mainly diagnosed and treated in general practice in the 
Netherlands Spirometry is an important tool within the broad concept of 
management in chronic respiratory diseases (COPD and asthma) and is necessary 
for diagnosing these conditions However, there still are a number of practical 
barriers that impede wide implementation of quality spirometry facilities in general 
practice the absence of properly trained staff, the lack of time and practice support to 
fit spirometry into the daily practice routine, the absence of a spirometer in the own 
practice, and GP's lack of confidence in the ability to interpret the test The latter 
barrier could theoretically be overcome through expert support Expert support for the 
interpretation of tests of pulmonary function may be made available - depending on 
local circumstances - as a software expert support system or by consultation or 
feedback from a chest physician However the value of expert support for GPs with 
respect to the interpretations of spirometry tests and their subsequent management 
of patients with (suspected) chronic respiratory disease was not known 
To provide further evidence on this issue, we performed two cross-sectional studies 
to get insight into the variation m spirometry utilisation between practices and GPs' 
needs for expert support in daily practice We designed two cluster-randomised trials 
on the impact of expert support for the interpretation of spirometry test results on the 
diagnostic achievements of GPs 
Chapter 2 
In this chapter we explored the spirometry utilisation for five indications from national 
COPD/asthma guidelines among GPs and identified GP-related and practice-related 
factors associated with spirometry utilisation For this purpose we used data from a 
questionnaire survey among 144 GPs from 61 general practices involved m a 
spirometry evaluation program GPs used spirometry mostly to evaluate treatment 
with inhaled steroids (-60%) Significant GP-related factors associated with 
spirometry utilisation were general practitioners' job satisfaction, general 
practitioners' general interest in research, and prior participation in spirometry 
training Practice-related factors associated with spirometry utilisation were presence 
of a practice nurse, delegation of medical tasks to practice assistants, use of 
spirometry in different rooms, and use of protocols in practice In conclusion, GP- as 
well as practice-related factors were associated with the extent of spirometry 
utilisation Especially practice related factors (e g presence of a practice nurse, more 
delegation of medical tasks to the practice assistant) are concrete to improve 
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Chapter 3 
In this chapter we determined GPs' needs for ongoing support for the interpretation of 
spirometry tests We used data from a questionnaire survey among 137 GPs 
involved m the m chapter 2 mentioned spirometry evaluation program Seven out of 
ten GPs expressed a need for ongoing support for the spirometry interpretation, 
preferably organised by a local chest physician or pulmonary function laboratory, or a 
computerised clinical decision support system Recent spirometry training partially 
diminished this need 
Chapter 4 
In this editorial the need for continuous advice and expert support for the 
interpretation of spirometry test results is depicted Although spirometry is more and 
more available in general practice, it is still underused due to practical issues and 
GPs' lack of confidence in the their ability to interpret the test results Ideally once 
GPs have had initial spirometry training they should receive continuous support by 
another GP with a special interest in respiratory disease in the same group practice, 
by means of a computerised decision support system, or by consultation or feedback 
from a chest physician Coordinated efforts by health policy makers and the medical 
profession will be needed to provide the right equipment, training for staff who use it, 
and continuing quality assurance and support for test interpretation The burden of 
COPD is sufficiently large to warrant such an approach 
Chapter 5 
In this chapter we report on the results of a simulated cluster-randomised trial of GP's 
diagnostic acuity of chronic respiratory disease in a process of diagnostic 
assessment of standardised cases Using a stepwise approach, 78 GPs completed 
10 standardised paper case descriptions each Intervention consisted of support for 
GPs' spirometry interpretation either by an expert system (expert support group) or 
by sham information (control group) Differences in GPs' diagnostic achievements 
and m GPs' decision-making before and after intervention were compared between 
the study groups Agreement of GPs' diagnoses was compared with an expert panel 
judgement, which served as the primary outcome Other decision-making related 
outcomes were additional diagnostic test rates, width of differential diagnosis, 
certainty of diagnosis, estimated seventy of disease, referral rate, and medication or 
non-medication changes We found no differences between the expert support and 
the control group in the agreement between the diagnosis of the GP and expert 
panel We observed only a slightly higher rate of additional diagnostic tests in the 
expert support group In conclusion, computerised spirometry expert support had no 
detectable benefit on GPs' diagnostic achievements and decision-making process 
when diagnosing chronic respiratory disease 
83 
Chapter 6 
In this chapter a study was presented to assess the impact of two modes of expert 
support for the interpretation of spirometry tests on general practitioners' (GPs) 
diagnosis and subsequent management of chronic respiratory disease In a cluster-
randomised controlled trial, with general practices as unit of randomisation, GPs from 
44 practices recorded their diagnosis and management before and after interpreting 
spirometrie test results in 868 patients Intervention consisted of software support or 
chest physician support versus no support (usual care) for the interpretation of the 
tests The primary outcome was change of GPs' prior diagnoses after spirometry 
Other decision-making related outcomes were additional diagnostic tests rate, 
referral rate, and changes in pharmacotherapy Spirometry was important for GPs' 
diagnosis but no added value on their decision-making could be found for software 
expert support or chest physician support in establishing a final diagnosis in patients 
with chronic respiratory symptoms In over 40% of cases spirometry led to modifying 
the diagnosis Not surprisingly, diagnoses changed more often in patients in whom a 
formal diagnosis had not been made prior to spirometry but this was the case in all 
three study groups Overall, support for the interpretation of spirometry tests did not 
seem to influence GP's decision-making process 
Chapter 7 
In this chapter the results of the different studies are discussed using current 
literature Its implications are discussed, as well as some recommendations are 
given This thesis showed that there is variation in spirometry utilisation among 
practices and showed that GPs have a need for continuous support for the 
spirometry test results However, neither support by expert software nor by a chest 
physician had influence on the diagnostic achievements of GPs and subsequent 
management in patients with respiratory conditions We therefore should continue to 
focus on both factors that make GPs uncertain to interpret the tests and on new 
COPD support services to enhance spirometry utilisation and interpretation in general 
practice 
84 
Samenvatting 
Hoofdstuk 1 
In dit hoofdstuk wordt de achtergrond van dit proefschrift beschreven COPD (chrome 
obstructive pulmonary disease) en astma zijn beiden veel voorkomende chronische 
luchtwegaandoeningen, die grotendeels m de huisartsenpraktijk worden 
gediagnosticeerd en behandeld COPD en astma behoren wereldwijd tot de 
hoofdoorzaken van ziekte en sterfte (vooral COPD) Om deze aandoeningen te 
diagnosticeren is toepassing van spirometrie noodzakelijk Toch gebruiken lang met 
alle huisartsen daadwerkelijk de spirometer Naast een aantal praktische redenen als 
te weinig tijd, scholing en ruimte m de praktijk, blijkt vooral de interpretatie van de 
spirometrie uitslagen voor de huisarts een knelpunt voor uitgebreide toepassing 
Een mogelijke oplossing hiervoor is een meer routinematige ondersteuning voor de 
huisarts bij de beoordeling van de spirometrie uitslagen Dit zou bijvoorbeeld kunnen 
met behulp van een geautomatiseerd expertsysteem, geïnstalleerd m de 
spreekkamer Dit programma geeft de huisarts patientspecifieke informatie over de 
spirometrie test Een andere optie is patientspecifieke teleconsultatie of feedback van 
een longarts door de uitslagen van een spirometrie test uit de huisartsenpraktijk naar 
de longarts te faxen voor beoordeling Hoewel deze vormen van "expert support" in 
Nederland in de praktijk daadwerkelijk gebruikt worden, is het met bekend of deze 
vormen van ondersteuning wel effectief zijn 
Om meer inzicht te krijgen m de hierboven beschreven onderwerpen, hebben we een 
aantal studies opgezet Naast twee clustergerandomiseerde trials om de invloed van 
routinematige ondersteuning vast te stellen op de diagnostiek en het beleid bij 
patiënten bij wie de huisarts een chronische luchtwegaandoening vermoedt, zijn een 
tweetal cross-sectionele onderzoeken uitgevoerd 
Hoofdstuk 2 
In dit hoofdstuk wordt onderzocht hoe Nederlandse huisartsen gebruik maken van 
spirometrie in hun praktijk Er werd gekeken of er een relatie bestond tussen een 
aantal huisarts- en praktijkkenmerken en de mate van daadwerkelijke spirometrie 
inzet voor vijf indicaties voor spirometrie afkomstig uit de NHG-standaarden In totaal 
namen 61 praktijken met 144 huisartsen deel aan het onderzoek Uit het onderzoek 
blijkt dat huisartsen spirometrie voornamelijk gebruiken om te evalueren of een 
behandeling met mhalatiesteroiden aanslaat (58 procent) Belangrijke factoren die 
werden geassocieerd met het gebruik van spirometrie zijn plezier in het werk, 
interesse in onderzoek en deelname aan spirometrie trainingen Binnen de praktijk 
zijn er tevens factoren die bijdragen aan het wel of met toepassen van spirometrie 
De aanwezigheid van een praktijkondersteuner, de mate van delegeren van 
medische taken naar de praktijkassistente, het toepassen van protocollen en het 
gebruik van spirometrie in verschillende ruimtes in de praktijk Vooral 
praktijkgerelateerde kenmerken lijken duidelijk verbeterbaar 
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Hoofdstuk 3 
In dit hoofdstuk wordt onderzocht of huisartsen behoefte hebben aan routinematige 
ondersteuning bij de spirometrie uitslagen Er werd gekeken of er een relatie bestond 
tussen een aantal huisarts- en praktijkkenmerken en de behoefte aan ondersteuning 
We gebruikten hiervoor informatie van een vragenlijst onderzoek onder 137 
huisartsen die deelnamen aan een spirometrie evaluatie studie (hoofdstuk 2) Uit het 
onderzoek blijkt dat 69% van de huisartsen behoefte heeft aan routinematige 
ondersteuning bij de interpretatie van spirometrie uitslagen De voorkeur van de 
huisartsen gaat uit naar ondersteuning door een regionale longarts, een regionaal 
huisartsenlaboratorium, of een geautomatiseerd expertsysteem De behoefte aan 
routinematige ondersteuning was lager indien de huisarts recent een spirometrie 
nascholing had bijgewoond 
Hoofdstuk 4 
Dit hoofdstuk betreft een redactioneel artikel over de beschikbaarheid van 
spirometrie en de toepassing ervan in de eerste lijn Hoewel steeds meer huisartsen 
in westerse landen de beschikking hebben over een eigen spirometer, is het gebruik 
m de dagelijkse praktijk hiervan laag Naast een aantal praktische redenen als te 
weinig tijd, scholing en ruimte in de praktijk, blijkt vooral de interpretatie van de 
spirometrie uitslagen voor de huisarts een knelpunt voor uitgebreide toepassing 
Idealiter zou een huisarts na initiële spirometrie nascholing over routinematige 
ondersteuning bij de spirometrie uitslagen beschikken Dit zou bijvoorbeeld op drie 
manieren kunnen met behulp van een collega huisarts in dezelfde praktijk of 
huisartsengroep, met behulp van een geautomatiseerd expertsysteem geïnstalleerd 
m de spreekkamer, of met behulp patientspecifieke consultatie of feedback van een 
regionale longarts door de uitslagen van een spirometrie te faxen voor beoordeling 
Gezien de huidige prevalentie COPD is het noodzakelijk dat beleidsmakers en de 
beroepsgroepen van huisartsen en longartsen samen nadenken over de allocatie 
van spirometers en ondersteuning om het diagnostische proces van COPD m de 
eerste en tweede lijn optimaal te organiseren 
Hoofdstuk 5 
Het doel van de in hoofdstuk 5 beschreven studie was te bepalen wat de invloed is 
van een spirometne-expertsysteem op de diagnostiek en het beleid bij patiënten bij 
wie de huisarts een chronische luchtwegaandoening vermoedt We organiseerden 
een clustergerandomiseerde trial onder 78 huisartsen die elk 10 gestandaardiseerde 
casusbeschrijvingen beoordeelden De interventie bestond uit input van een 
expertsysteem (SpidaXpert®) bij de casusevaluatie, de huisartsen m de 
controlegroep ontvingen alleen de volume-tijd curve als aanvullende informatie We 
vergeleken verschillen in de diagnostiek en het beleid van de huisarts bij de 10 casus 
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voor en na interventie tussen de twee groepen De primaire uitkomst was de mate 
van overeenstemming van de diagnose van de huisarts met die van een expertpanel 
Secundaire uitkomstmaten waren aanvragen voor aanvullend onderzoek, 
verwijzingen naar een specialist, 'breedte' van de differentiaaldiagnose, mate van 
zekerheid over de diagnose, ingeschatte ernst van de aandoening en wijzigingen m 
medicatie Er was geen verschil tussen de huisartsen in de expertsysteem- en 
controlegroep wat betreft het correct vaststellen van de diagnoses Wel vroegen de 
huisartsen in de expertsysteemgroep iets meer aanvullend onderzoek aan 
Hoofdstuk 6 
Dit hoofdstuk betreft een studie naar de invloed van routinematige ondersteuning bij 
de interpretatie van spirometrie uitslagen met behulp van een spirometne-
expertsysteem of een longarts op de diagnostiek en het beleid bij patiënten bij wie de 
huisarts een chronische luchtwegaandoening vermoedt In een 
clustergerandomiseerde trial, met huisartspraktijken als eenheid van randomisatie, 
legden huisartsen uit 44 praktijken voor en na spirometrie hun diagnose en beleid 
vast bij 868 patiënten De interventie bestond uit of input van een expertsysteem 
(SpidaXpert®) of hulp van een regionale longarts versus geen hulp bij de beoordeling 
van spirometrie uitslagen De primaire uitkomst was de mate van verandering van de 
huisartsdiagnose De secundaire uitkomsten waren aanvragen voor aanvullend 
onderzoek, verwijzingen naar een specialist en wijzigingen in medicatie Hoewel 
spirometrie belangrijk was voor de diagnostiek van de huisarts, was er geen verschil 
tussen de huisartsen in de expertsysteemondersteunde of longartsondersteunde 
groep en de controlegroep wat betreft verandering van de diagnoses of verandering 
m beleid In 40% van de patiënten veranderde de diagnose na interventie De 
verandering vond voornamelijk plaats bij patiënten die nog geen luchtwegaandoening 
hadden 
Hoofdstuk 7 
In de algemene discussie in hoofdstuk 7 worden de belangrijkste bevindingen van dit 
proefschrift geplaatst in een breder kader van huidige wetenschappelijke kennis 
Daarnaast worden relevante methodologische aspecten van de studies besproken 
en aanbevelingen voor toekomstig onderzoek gegeven Dit proefschrift laat zien dat 
er variatie is m het gebruik van spirometrie in huisartspraktijken Bovendien hebben 
huisartsen behoefte aan ondersteuning bij de interpretatie van de spirometne-
uitslagen Echter, noch ondersteuning door een spirometne-expertsysteem noch door 
een longarts bleek effect te hebben op de diagnostiek en het beleid bij patiënten bij 
wie de huisarts een chronische luchtwegaandoening vermoedt Daarom zal 
toekomstig onderzoek zich moeten richten op enerzijds het achterhalen van redenen 
waarom huisartsen onzeker zijn over hun interpretatie van spirometrie uitslagen 
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Anderzijds zal het zich moeten richten op de optimale organisatie van de spirometrie 
uitvoering en interpretatie m de eerste of tweede lijn 
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Dankwoord 
•y 
Mijn proefschrift is af Een kort overzicht van de bewandelde weg Na toelating tot de 
huisartsopleidmg m Nijmegen (2002) kreeg ik de gelegenheid om me te oriënteren 
welk onderzoek ik wilde verrichten Na een aantal verkennende gesprekken koos ik 
voor het huidige SPRINT onderzoek (Spirometrie in de huisartspraktijk interpretatie 
en integratie) Vanaf 2003 heb ik de huisartsopleidmg gecombineerd met dit 
onderzoek Deze combinatie was met altijd even gemakkelijk ik verkeerde immers in 
twee werkkringen met regelmatig tegengestelde agenda's Met dank aan mijn beide 
huisartsopleiders - Wim van Jaarsveld (Ede) en Christine Schellevis (Terborg) -
rondde ik in 2005 het huisartsendeel van mijn opleiding af Nu, een aantal jaar later, 
is ook het onderzoek klaar Dit proefschrift was natuurlijk nooit tot stand gekomen 
zonder de hulp en inzet van een heleboel andere mensen Ik wil een aantal mensen 
in willekeurige volgorde hiervoor bedanken 
Beste Chris van Weel, jouw betrokkenheid was heel bijzonder JIJ wist de grote lijn te 
bewaken en de resultaten in (inter)nationaal perspectief te plaatsen Hoewel JIJ 
regelmatig op plaatsen zat in de wereld waar ik nooit ben geweest en waarschijnlijk 
nooit zal komen, lukte het jou toch om van daaruit zeer snel te reageren op mijn 
artikelen Dank voor deze intensieve betrokkenheid Ik vind het een grote eer te 
mogen promoveren bij de president van de WONCA (World Organization of Family 
Doctors) 
Beste Pieter de Vries Robbe, JIJ reduceerde complexe vragen en problemen voor mij 
tot simpele pijldiagrammen en schema's JIJ wist het onderzoek te verbreden over de 
grenzen van het "astma & COPD wereldje" Ik heb jouw begeleiding als zeer prettig 
ervaren 
Beste Tjard Schermer, jouw eigen promotie ging vooraf aan mijn onderzoek 
Daardoor zat JIJ heel goed m het onderwerp JIJ wist moeilijke methodologische 
problemen voor mij transparant te maken, zonder alles te verhullen Hoewel onze 
werkstijlen totaal verschillend waren, vulden we elkaar prima aan Zeer bedankt voor 
je enorme hulp 
Beste Ben Bottema, JIJ hield de toepasbaarheid van de resultaten voor huisartsen m 
de gaten Door delen van onze nascholingen te accrediteren was de belangstelling 
voor dit onderzoek groot onder huisartspraktijken Jouw overstap van 
handgeschreven commentaar naar digitaal commentaar was voor mij zeer 
verhelderend Dank voor je begeleiding 
De continuïteit van dit onderzoek werd gegarandeerd door Margreet van den Bogart-
Jansen en Joke Grootens-Stekelenburg Margreet, JIJ was het gezicht van het 
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SPRINT onderzoek Voordat ik begon had JIJ de lijntjes al uitgezet JIJ werkte aan 
diverse projecten tegelijkertijd Als duizendpoot stond je altijd voor iedereen klaar 
Bedankt voor je enorme inzet Joke, gaandeweg heb JIJ mij geholpen met het 
datamanagement Jouw systematische wijze van gegevens invoeren en controleren 
was van cruciaal belang om tot betrouwbare resultaten te kunnen komen Ik wil ook 
hier de andere onderzoeksassistenten bedanken Antoinette Marks voor het 
bezoeken van de vele huisartspraktijken, Riet Cretier en Nicole Orbon voor het 
beantwoorden van vragen en telefoontjes van de deelnemers 
Mijn dank gaat uit naar de deelnemende huisartsen, longartsen, assistentes, 
praktijkondersteuners en patiënten die enthousiast hebben meegewerkt aan dit 
onderzoek 
Ik bedank de leden van de begeleidingscommissie Philip Quanjer voor de altijd 
uitgebreide kritische antwoorden op mijn e-mails, Bart Thoonen voor het bewaken 
van de belangen van de astmapatienten in dit meer COPD-geonenteerde onderzoek, 
Annelies Jacobs voor de inbreng van patiëntgerichte zaken en kennis over 
vragenlijsten en natuurlijk Henk van den Hoogen en Hans Folgenng voor het 
meedenken in de opzetfase van dit onderzoeksproject 
Ik wil Reiner Akkermans en Waling Tiersma bedanken voor de inbreng van 
statistische- en informatica kennis Dank ook aan de Daan Schellekens voor het 
meehelpen aan een deelstudie in het kader van een wetenschappelijke stage 
Ik bedank mijn collega-onderzoekers voor hun gezelligheid en steun Ik zal de 
gemeenschappelijke initiatieven (nascholingen, ingezonden brieven, 
refereeravonden, lunchen en congresbezoeken) wel gaan missen Dank aan de 
collega's op de afdeling waar ik altijd met vragen terecht kon Twanny, Caroline, 
Dorothe en Annemarie (secretaresses), bedankt voor de goede zorgen en het feit dat 
ik altijd een beroep op jullie kon doen 
Beste oud-collega's uit Utrecht en Rotterdam, bij jullie heb ik de kunst kunnen 
afkijken hoe kwalitatief goed onderzoek er uit kan zien Jullie enthousiasme is debet 
geweest aan de start van mijn eigen onderzoek, weliswaar in Nijmegen 
Beste Felix de Jong, het prille begin van onderzoek lag m jouw KNO-praktijk m 
Veghel Dank voor de prettige samenwerking 
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Beste collega's in de huisartspraktijk m Huissen Een grote verandering staat voor de 
deur Ik heb meer tijd nu om daar de schouders onder te steken Ik ben blij met jullie 
te kunnen samenwerken 
Beste Martijn, Raijmond en Jesper, het is toch wel bijzonder dat we allemaal 
gepromoveerd dokter zijn geworden Jullie vriendschap, steun en interesse is voor 
mij zeer bijzonder "Te druk met promoveren" is voor geen van ons nu meer een 
geldige handicap op de golfbaan 
Vrienden, familie en buren in Arnhem, bedankt voor jullie interesse naar de 
voortgang van mijn onderzoek en de broodnodige afleiding 
Ik wil mijn familie en schoonmoeder bedanken voor hun belangstelling Frans en 
Flory, bedankt voor jullie steun en aanwezigheid in mijn leven bij de mooie en 
mindere momenten De verbondenheid met jullie en met Danielle en Murielle, mijn 
twee zussen, is bijzonder Hoewel ieder van ons druk is met het werk, het gezin, de 
kinderen of vrije tijd, zowel in Nederland of daarbuiten, waardeer ik jullie 
betrokkenheid bij belangrijke momenten heel erg Juul, bedankt voor je interesse, 
ondanks dat het voor jou met altijd een makkelijke tijd was 
Lieve Manon, JIJ hebt me de vrijheid gegeven dit onderzoek te realiseren JIJ weet 
hoeveel avonduurtjes ik heb gestoken m dit boekje Terecht probeerde JIJ regelmatig 
het belang van promoveren te relativeren Met de komst van Charlotte en Pieter lukte 
mij dit ook makkelijker Ik ben erg blij dat jullie er altijd zijn 
94 
Curriculum Vitae 
• 
Patrick Poels was born on 29 January 1972 in Nijmegen, The Netherlands. He grew 
up in Molenhoek. In 1990 he passed secondary school at the 'Nijmeegse 
Scholengemeenschap Groenewoud' in Nijmegen (atheneum). He started Agricultural 
Economics at the Wageningen University. After passing his propaedeutical exam in 
1991, he started Medical School at the Radboud University Nijmegen (previously 
'Katholieke Universiteit Nijmegen'). He graduated from Medical School in 1998. 
Subsequently, he worked as a resident at the Emergency Department in Hospital 
Bernhoven in Veghel (1998-1999), and at the Department of Surgery in VieCuri 
Medical Centre in Venlo (1999-2000). Meanwhile he started research on vocal fold 
lesions at the Department of Otorhinolaryngology in Hospital Bernhoven (Prof. dr. 
F.I.CR.S de Jong) m 1998. In 2000 he participated in research on the efficacy of 
adenotonsillectomy in children at the Julius Center for Health Sciences and Primary 
Care (Prof. dr. A.W. Hoes and dr. A.G.M. Schilder, University Medical Centre 
Utrecht). In 2002 he started with the 3-year General Practitioner's training at the 
Radboud University Nijmegen Medical Centre. 
In 2003 he started with the so-called 'combined residency and research-training 
program (AIOTHO)' at the Department of General Practice (Prof. dr. C. van Weel) of 
the Radboud University Nijmegen Medical Centre, resulting in the work described in 
this thesis. 
In 2005 he started working as a general practitioner in general practice. 
He is married to Marion Poels-de Bruijn. They live in the city of Arnhem. They have 
two children, Charlotte (2003) and Pieter (2005). 
96 
Stellingen 
Behorend bij het proefschrift 
Spirometry expert support in general practice 
1. Spirometrie expert support heeft geen meetbare invloed op het 
diagnostisch handelen van de huisarts (dit proefschrift) 
2. De huisarts is bekwaam in het diagnosticeren van veel 
voorkomende chronische luchtwegaandoeningen (dit 
proefschrift) 
3. Er is een lange adem nodig om de spirometrie uitvoering en 
interpretatie in de eerste lijn te optimaliseren (dit proefschrift) 
4. Exploratie van de onzekerheid bij spirometrie interpretatie onder 
huisartsen is mogelijk met kwalitatief onderzoek (dit proefschrift) 
5. Waar vakmanschap ontbreekt, krijgen kengetallen steeds meer 
nadruk (intensieve Menshouderij; hoe kwaliteit oplost in 
rationaliteit. Peters & Pouw, Scriptum 2004) 
6. Als je kind gezond is heb je wel duizend wensen, als je kind ziek 
is heb je er maar één 
7. "Een muesli sandaal" is een sociometrisch voorbeeld om snel 
mee uit de voeten te kunnen 
8. "Made in Holland" wordt niet meer gemaakt 
9. De incidentie van zeldzame ziekten lijkt in bepaalde families 
hoger 
10. "Keuzemoeheid" is een nieuwe aandoening die veroorzaakt 
wordt door overmatige marktwerking in de zorg en samenleving 
Patrick Poels 
Nijmegen, 11 maart 2008 



